Psoriasis: every question, answered

Plaque psoriasis has a distinctive look once you know what to check. The plaques are well demarcated, stopping abruptly at a clear border rather than fading out, and carry adherent silvery-white scale that leaves pinpoint bleeding if picked off. Distribution favours extensor surfaces — the outsides of elbows and knees — along with the scalp, the lower back and the cleft between the buttocks, and the navel. It is usually symmetrical. Itch is present in most people but less dominant than in eczema, and soreness or cracking is often the bigger complaint. The single most useful confirming feature sits at your fingertips: nail pitting, oil-drop discolouration or separation of the nail from its bed occurs in a large share of people with psoriasis and rarely accompanies its look-alikes. Two more clues: new plaques appearing along a scratch or scar, which is the Koebner phenomenon, and a family history. Diagnosis is clinical, with biopsy reserved for genuine uncertainty.

• Therapy guidePsoriasis therapy guide
• ToolPASI Calculator
• ToolBSA Calculator
• QuestionWhat do the changes in my nails mean?
• QuestionCould this be a fungal infection instead?

Tinea and psoriasis are confused often, and the consequences run one way: a steroid applied to ringworm suppresses the visible inflammation while the fungus spreads, producing an odd, indistinct, expanding rash. Distinguishing features. Ringworm is often solitary or asymmetric, has a raised active scaly border with a flatter centre, and frequently coexists with athlete's foot or nail involvement. Psoriasis is usually symmetrical, uniformly thick across the plaque, favours extensor surfaces, and comes with nail pitting rather than the crumbling thickening of fungal nails. Scalp involvement complicates things further, since tinea capitis in children causes hair loss and swollen glands, which scalp psoriasis does not. The distinction is easily settled: skin scrapings examined under a microscope or cultured give an answer, and asking for that is reasonable when a rash has not responded to psoriasis treatment. Two other look-alikes worth knowing: pityriasis rosea, which starts with a single herald patch and resolves on its own, and discoid eczema, which is itchier and less sharply bordered.

• Therapy guidePsoriasis therapy guide
• QuestionHow can I tell these patches are psoriasis?
• QuestionWhat tests will confirm psoriasis?

Psoriasis on the hands and feet is disproportionately disabling relative to how little body surface it covers, and severity scores based on area badly understate it. Two patterns occur. Palmoplantar plaque psoriasis produces thickened, scaly, well-defined areas that crack into painful fissures, making gripping, walking and manual work genuinely difficult. Palmoplantar pustulosis produces crops of sterile pustules that dry to brown spots on a background of thickened red skin — the pustules contain no infection, so antibiotics do nothing, and the condition is strongly associated with smoking. Distinguishing them from hand eczema and fungal infection matters and is not always straightforward; a scraping excludes fungus, and both eczema and psoriasis can look similar here, with a biopsy occasionally needed. What follows practically: this presentation justifies systemic treatment even with minimal body-surface involvement, because function and quality of life carry weight in treatment decisions. Say what you cannot do rather than how much skin is affected.

• Therapy guidePsoriasis therapy guide
• ToolBSA Calculator
• QuestionMy psoriasis covers a small area — does that mean it's mild?
• QuestionHow much do smoking and drinking affect psoriasis?

Inverse or flexural psoriasis behaves unlike the classic picture, which is why it goes unrecognised. It occupies the armpits, groin, under the breasts, the buttock cleft and the navel, and because those areas stay moist the scale never develops — so instead of thick silvery plaques you get smooth, shiny, sharply bordered red or violaceous areas that may fissure painfully in the crease. It is frequently misdiagnosed as a fungal infection or intertrigo, and treated with antifungals that do nothing. Confirming clues are psoriasis elsewhere, nail changes and a family history, and a swab or scraping can exclude candida, which genuinely does colonise these areas and sometimes coexists. Treatment differs from plaque psoriasis in one important respect: skin in the folds is thin and occluded, which increases steroid absorption substantially, so potent steroids are avoided and mild ones are used briefly. Calcineurin inhibitors and vitamin D analogues are commonly preferred for maintenance, and keeping the area dry and friction-free matters as much as any cream.

• Therapy guidePsoriasis therapy guide
• QuestionHow do I treat psoriasis on my face or in the folds?
• QuestionHow can I tell these patches are psoriasis?

The two overlap enough to have their own hybrid label, sebopsoriasis, but the extremes are distinguishable. Scalp psoriasis produces raised, sharply bordered plaques with thick silvery scale that can be felt as distinct lumps, often extending a centimetre or two past the hairline onto the forehead, behind and inside the ears, and down the back of the neck. Seborrhoeic dermatitis produces finer, greasier, yellowish flaking spread diffusely across the scalp with less definition and no palpable thickening, and it usually itches more. Supporting evidence for psoriasis: plaques elsewhere on the body, nail pitting, and a family history. Treatment diverges — seborrhoeic dermatitis responds to antifungal shampoos, psoriasis needs descaling agents such as salicylic acid or coconut-oil preparations followed by a potent steroid scalp application or a vitamin D analogue, applied to the scalp rather than to the hair. Both are common, both are treatable, and having one does not exclude the other.

• Therapy guideDandruff therapy guide
• QuestionWhat is the right way to treat scalp psoriasis?
• QuestionHow can I tell these patches are psoriasis?

Guttate psoriasis appears abruptly, often in children and young adults, as dozens to hundreds of small teardrop-shaped scaly papules scattered across the trunk, arms and legs, usually sparing the palms and soles. The classic trigger is a streptococcal infection — tonsillitis or a sore throat — one to three weeks earlier, and a throat swab or blood test for streptococcal antibodies is sometimes done to confirm the link. Its behaviour differs from plaque psoriasis: it frequently resolves over weeks to months on its own or with phototherapy, and many people never develop psoriasis again, though a proportion go on to chronic plaque disease later. Treatment is usually emollients, topical steroids or vitamin D analogues, phototherapy for widespread involvement, and antibiotics if an active streptococcal infection is present, though treating the throat does not reliably clear the skin. The look-alikes worth excluding are pityriasis rosea, which starts with a single larger herald patch, and secondary syphilis, which can involve the palms and soles.

• Therapy guidePsoriasis therapy guide
• ToolBSA Calculator
• QuestionCan an infection start psoriasis off?
• QuestionWhat is light treatment actually like?

Psoriasis is diagnosed by looking at the skin, the nails and the history, and expecting a definitive test delays treatment. There is no blood marker for it. Where tests appear, they answer specific questions. A skin biopsy is used when the picture is atypical or when a serious mimic needs excluding, most notably cutaneous T-cell lymphoma, which can present as persistent scaly patches for years. Skin scrapings or a swab exclude fungal infection, which is a genuine consideration for isolated patches, nails, and anything on the palms, soles or folds. A throat swab or streptococcal antibody test may be done in sudden guttate presentations. Blood tests come later and are about safety rather than diagnosis: baseline and ongoing monitoring for methotrexate and ciclosporin, and screening for tuberculosis and hepatitis before biologics. Two additional things a good assessment covers: joints, because psoriatic arthritis is common and under-detected, and cardiovascular risk factors, which are raised in psoriasis and worth measuring.

• Therapy guidePsoriasis therapy guide
• ToolPsoriatic Arthritis Screen
• ToolDerm Visit Prep
• QuestionHow can I tell these patches are psoriasis?
• QuestionShould I be screened for psoriatic arthritis?

Four features usually separate them. Itch: intense and dominant in eczema, present but often secondary to soreness in psoriasis. Edges: eczema patches fade into normal skin, psoriasis plaques stop abruptly at a clear border. Scale: psoriasis produces thick, adherent, silvery-white scale that leaves pinpoint bleeding if picked off, while eczema scale is finer and often accompanied by weeping or crusting during a flare. Distribution: psoriasis prefers the outside of elbows and knees, the scalp, the lower back and the navel; eczema prefers the inside of elbows and knees, the neck, the hands and the eyelids. Two extra clues favour psoriasis strongly — nail pitting or separation, and any joint pain or stiffness, which needs mentioning because psoriatic arthritis benefits from early treatment. Overlap exists and a biopsy is occasionally needed. The distinction matters practically: emollient volume is the foundation for eczema, while psoriasis leans on vitamin D analogues and has a different escalation ladder.

Shared with Eczema, where this answer lives.

• Therapy guidePsoriasis therapy guide
• ToolPsoriatic Arthritis Screen
• ToolPASI Calculator
• QuestionIs this eczema or just dry skin?
• QuestionCan I have eczema and psoriasis at the same time?

The link between streptococcal infection and psoriasis is one of the best-documented trigger relationships in dermatology. A sore throat or tonsillitis caused by group A streptococcus commonly precedes a guttate eruption by one to three weeks, particularly in children and young adults, and recurrent streptococcal infection is associated with flares of established plaque psoriasis. HIV infection is associated with severe, treatment-resistant psoriasis, and any new severe psoriasis warrants consideration of testing. Other infections and illness generally can destabilise the condition. What follows practically is more limited than the mechanism suggests. Treating an active streptococcal infection with antibiotics is appropriate on its own merits, but trials have not shown antibiotics reliably clearing the resulting psoriasis, and tonsillectomy is not routinely recommended despite some evidence in selected people with recurrent tonsillitis and refractory disease. Two things worth doing: mention a recent sore throat if psoriasis appears suddenly, since it supports the diagnosis; and get recurrent throat infections properly assessed rather than repeatedly self-treating.

• Therapy guidePsoriasis therapy guide
• QuestionWhat are these sudden small drop-shaped spots?
• QuestionWhat sets off a psoriasis flare?

These are among the few modifiable factors with solid evidence behind them. Smoking increases the risk of developing psoriasis, increases severity in those who have it, reduces response to treatment including biologics, and is strongly associated with palmoplantar pustulosis — a variant that frequently improves substantially on stopping, which is a rare instance of a lifestyle change producing visible skin improvement. Alcohol is associated with more severe disease, poorer treatment response and reduced adherence, and it matters additionally because several psoriasis drugs — methotrexate above all, plus aciclitretin and some others — carry liver considerations that alcohol compounds. Both also feed the cardiovascular and metabolic risk that psoriasis independently raises. None of this is said as reproach, and both are genuinely hard to change, particularly when the condition itself is a stressor. What is worth knowing is that the return here is unusually concrete: stopping smoking improves the skin, improves how well treatment works, and reduces a cardiovascular risk that is already elevated. Support to stop is a reasonable thing to ask for.

• Therapy guidePsoriasis therapy guide
• QuestionIs the cracking on my palms and soles psoriasis?
• QuestionWhy am I being told to check my blood pressure and cholesterol?

The association is well documented, with a substantial proportion of people identifying stress as a trigger and studies showing flares following stressful periods. The mechanism is plausible: the hypothalamic-pituitary-adrenal axis and the nervous system interact directly with the immune pathways driving psoriasis, and neuropeptides released in skin under stress amplify inflammation. What complicates it is direction. Psoriasis causes stress at least as reliably as stress causes psoriasis — visible plaques, itching, sleep disruption and the social consequences all take a toll, and studies find high rates of depression and anxiety in this population. So the loop is genuine and the advice to relax is useless. What helps in practice: treating the psoriasis effectively, which reduces the largest stressor; psychological support alongside dermatological treatment, which has evidence for improving both mood and skin; and protecting the mechanics of the routine during difficult periods, since that is exactly when treatment gets abandoned. Stress management is worth doing for its own sake, not as a substitute for treatment.

• Therapy guidePsoriasis therapy guide
• ToolSkin Flare Diary
• QuestionIs it normal for psoriasis to affect my mood this much?
• QuestionWhat sets off a psoriasis flare?

Obesity and psoriasis have a bidirectional relationship supported by reasonable evidence. Adipose tissue is metabolically active and produces inflammatory cytokines that overlap with those driving psoriasis, so excess weight increases severity and reduces the response to several systemic treatments, including some biologics that are dosed by weight. In the other direction, psoriasis is associated with weight gain through inflammation, reduced physical activity where joints hurt or plaques are painful, and the mental health burden. Intervention studies show weight reduction improving psoriasis severity and improving response to treatment, which is one of the stronger lifestyle findings in this field. Saying so risks sounding like blame, and it should not: this is a metabolic association within an inflammatory disease, not a moral matter, and plenty of people with severe psoriasis are not overweight. What is worth acting on is the whole cardiometabolic package rather than the number alone — blood pressure, glucose, lipids and activity — since psoriasis raises risk across all of them and that risk is more consequential than the plaques.

• Therapy guidePsoriasis therapy guide
• QuestionWhy am I being told to check my blood pressure and cholesterol?
• QuestionWill changing my diet clear psoriasis?

Psoriasis has one of the stronger genetic signals in dermatology. Twin studies show high concordance in identical twins, more than sixty susceptibility loci have been mapped, and the strongest single association is with a gene region called HLA-C*06:02, which is linked particularly to early-onset disease and guttate presentations. Roughly a third of people with psoriasis have a first-degree relative affected. Risk rises with one affected parent and considerably more with two, but it is not deterministic — plenty of people with the genetic background never develop it, which is why environmental triggers matter so much. Two practically useful implications. Family history helps diagnostically when a rash is ambiguous, so it is worth mentioning even if the relative was never formally diagnosed. And it displaces blame, which attaches to this condition persistently: psoriasis is not caused by anything you ate, failed to wash, or did wrong. Genetic testing has no role in routine care, since knowing your genotype does not change treatment.

• Therapy guidePsoriasis therapy guide
• QuestionWhat actually causes psoriasis?
• QuestionWill my children inherit psoriasis?

Psoriasis is an immune-mediated inflammatory disease rather than a skin problem that happens to look inflamed. Specific immune cells become activated and release cytokines, particularly interleukin-17, interleukin-23 and tumour necrosis factor, which drive keratinocytes to multiply far faster than normal — skin cells that should take about a month to reach the surface do so in days, piling up as the characteristic scale — while recruiting more inflammation and new blood vessels, which is why plaques are red and bleed when scale is removed. That cytokine map is not academic: it is precisely why modern biologics targeting IL-17 and IL-23 work as well as they do. Genetics supply the susceptibility, with more than sixty associated gene regions identified and a strong family history in many people. Environment supplies the trigger — streptococcal infection, skin injury, certain medications, smoking, obesity, alcohol and stress are the well-documented ones. Nothing in that list is a personal failing, and nothing about hygiene or diet causes psoriasis.

• Therapy guidePsoriasis therapy guide
• QuestionHow much of psoriasis is inherited?
• QuestionWhat sets off a psoriasis flare?

Triggers in psoriasis are better characterised than in most skin conditions, and several are actionable. Streptococcal throat infection is the clearest, classically preceding guttate flares by one to three weeks. Skin injury of any kind — a scratch, a burn, a tattoo, a surgical scar, even a tight waistband — can produce new plaques at the site, known as the Koebner phenomenon. Medications are a major and under-recognised category: lithium, beta-blockers, antimalarials, and abrupt withdrawal of oral corticosteroids, which can precipitate severe or pustular disease. Smoking and excess alcohol both worsen psoriasis and reduce treatment response. Obesity contributes independently. Stress is genuinely associated, though the direction runs both ways. Cold, dry weather worsens it for most people while sunlight often helps. What is not on the list, despite the internet's confidence: gluten in people without coeliac disease, nightshades, and dairy. Knowing your own triggers is useful; the one worth acting on hardest is stopping smoking, which improves both the disease and its cardiovascular company.

• Therapy guidePsoriasis therapy guide
• ToolSkin Flare Diary
• QuestionCan my other medications be making it worse?
• QuestionCan an infection start psoriasis off?

The observation behind the question is correct: natural sunlight improves psoriasis for most people, and ultraviolet light is a genuine treatment. The leap to sunbeds does not follow. Commercial tanning units emit predominantly UVA, which is far less effective against psoriasis than the narrowband UVB used medically, and they deliver it at doses optimised for tanning rather than for treating disease — with well-established increases in melanoma and non-melanoma skin cancer risk, particularly with use under thirty-five. Medical phototherapy differs in every relevant way: a specific wavelength around 311 nm, doses calculated from your skin type, gradual escalation, eye and genital protection, cumulative exposure tracked across your lifetime, and supervision. It is also usually free or low-cost through health services where sunbeds are not. Sensible use of natural sunlight is reasonable — short regular exposures, avoiding burning, since sunburn triggers the Koebner phenomenon and worsens psoriasis. Ask about phototherapy access rather than substituting a tanning salon for it.

• Therapy guidePsoriasis therapy guide
• ToolSun Safety Guide
• ToolSkin Cancer Risk Tier
• QuestionWhat is light treatment actually like?
• QuestionDoes sunlight genuinely help psoriasis?

The evidence here is thin but not empty. Indigo naturalis, a Chinese herbal preparation, has small trials showing benefit in plaque and nail psoriasis, with the practical drawback of staining everything blue. Aloe vera has mixed small studies. Dead Sea balneotherapy combined with sunlight has reasonable support, though separating the water from the light and the rest is impossible. Fish oil shows small effects in some trials. Mahonia aquifolium and capsaicin appear in the guideline review of alternative modalities with limited evidence. What to be careful about: herbal creams sold for psoriasis have repeatedly been found to contain undeclared potent corticosteroids, which means people believe a natural product cleared them while unknowingly using a steroid without supervision; and oral herbal preparations can interact with methotrexate and ciclosporin or affect the liver. The reasonable position is that these are adjuncts at best. If you use something, tell your clinician what it is, and do not substitute it for treatment of a disease with systemic consequences.

• Therapy guidePsoriasis therapy guide
• ToolIngredient Decoder
• QuestionDo any supplements help psoriasis?
• QuestionWill changing my diet clear psoriasis?

Scale is tempting to remove and satisfying to peel, and doing it mechanically works against you twice. It causes pinpoint bleeding, since psoriatic plaques sit over dilated capillaries close to the surface, and any skin injury can provoke fresh psoriasis at the site through the Koebner phenomenon, which is why aggressive descaling frequently makes a plaque larger rather than smaller. The productive approach is chemical and gradual. Salicylic acid preparations, urea, coconut-oil compound ointment on the scalp, or simply generous emollient applied and left to soften under occlusion will lift scale over days without trauma, and removing it genuinely helps — thick scale physically blocks topical treatments from reaching the plaque, so descaling first makes everything applied afterwards work better. Soak in a warm bath, apply emollient, and let scale come away with gentle wiping rather than force. Two related cautions: avoid abrasive scrubs and brushes on plaques entirely, and be careful with tight clothing and rubbing, which act as low-grade injury.

• Therapy guidePsoriasis therapy guide
• QuestionWhat is the right way to treat scalp psoriasis?
• QuestionWhat sets off a psoriasis flare?

Body surface area is a convenient measure and a poor one in isolation. A few plaques on the palms and soles that crack open make it painful to walk or work; genital psoriasis affects intimacy and is often too embarrassing to raise; scalp involvement is visible, itchy and sheds constantly; facial plaques carry the full social weight of the condition. Each of those can involve a fraction of one percent of your skin and justify systemic treatment. Guidelines and funding criteria increasingly recognise this through the concept of special sites and by incorporating quality-of-life measures alongside area scores, which is why the questionnaires you are asked to complete matter and are worth answering honestly rather than stoically. What to do with this: describe function and impact rather than extent. What you cannot do, what you avoid, how much sleep you lose, what it costs you at work. Two areas people systematically fail to mention: genitals and scalp. Both are common, both are treatable, and neither gets addressed unless raised.

• Therapy guidePsoriasis therapy guide
• ToolBSA Calculator
• ToolPASI Calculator
• ToolPGA×BSA Score
• QuestionIs the cracking on my palms and soles psoriasis?
• QuestionCan psoriasis affect the genitals?

Improvement in summer and deterioration in winter is a real and common pattern, and it reflects genuine pharmacology rather than mood: ultraviolet light suppresses the T-cell activity driving psoriasis locally in the skin, which is exactly why medical phototherapy exists and works. Sensible use of natural sunlight is therefore reasonable — short, regular exposures, building gradually, without burning. The critical limit is sunburn, which is a skin injury and can provoke new plaques at the site through the Koebner phenomenon, so a scorching fortnight can leave you worse than before. Two important caveats. A minority of people have photosensitive psoriasis that worsens with sun exposure, so if your skin reliably deteriorates in summer, that pattern is real and worth respecting. And several psoriasis medications increase photosensitivity or carry skin cancer considerations — methotrexate, ciclosporin and previous PUVA among them — which changes the calculation, so ask if you are on systemic treatment. Sunscreen on unaffected skin, sensible exposure on plaques, and no burning is the workable summary.

• Therapy guidePsoriasis therapy guide
• ToolSun Safety Guide
• QuestionSunlight helps — should I use a sunbed?
• QuestionWhat is light treatment actually like?

The terminology causes confusion and the practical answer is straightforward. Psoriasis is driven by the adaptive immune system attacking a person's own tissue, with T cells and the interleukin-17 and interleukin-23 pathways central, which is why it is described as immune-mediated inflammatory disease and why drugs blocking those cytokines work so well. Whether it qualifies as autoimmune in the strict sense has been debated, since it lacks the circulating autoantibodies that define conditions like lupus, though candidate autoantigens have been identified. For anyone living with it, the distinction changes nothing about management. What does follow from the immune-mediated framing is useful: psoriasis clusters with other immune-mediated conditions, notably psoriatic arthritis, inflammatory bowel disease and uveitis, so symptoms in the joints, gut or eyes deserve mentioning rather than being treated as unrelated; and immune-targeting treatments carry implications for infection risk, vaccination and screening. It also explains why nothing applied to the surface addresses the cause in moderate or severe disease.

• Therapy guidePsoriasis therapy guide
• QuestionWhat actually causes psoriasis?
• QuestionWhat else is psoriasis associated with?

Psoriasis cannot be caught or passed on, and the belief that it can is the source of most of the social damage the condition does. It arises from an immune system attacking a person's own skin; there is no organism to transmit. Yet people with visible plaques are still asked to leave swimming pools, refused treatment in salons and barbers, and avoided socially — surveys of people with psoriasis consistently document this, and it is a significant contributor to the psychological burden the condition carries. It is worth being able to say plainly that psoriasis is not contagious, and worth knowing that in many jurisdictions refusing a service on that basis may amount to unlawful discrimination against a long-term health condition. What does spread, in a sense that gets confused with contagion, is psoriasis onto your own injured skin — the Koebner phenomenon, where new plaques form at sites of scratches, tattoos or surgery. That is your immune system responding to injury, not infection moving anywhere.

• Therapy guidePsoriasis therapy guide
• QuestionWhat do I do if I'm refused service because of my skin?
• QuestionWhat actually causes psoriasis?

Treating psoriasis as an appearance issue is the framing that costs people most, because it delays the things that matter beyond the plaques. Psoriatic arthritis develops in a large minority — estimates commonly run up to around a third — and joint damage that accumulates during a diagnostic delay is irreversible. Cardiovascular and metabolic risk is approximately doubled, sufficient that guidance recommends active screening of blood pressure, lipids, glucose and weight rather than leaving it to chance. Depression and anxiety rates are high, and the association tracks disease impact rather than surface area. There are also links with inflammatory bowel disease, fatty liver disease and chronic kidney disease. What follows practically: severity is not measured by how much skin is involved but by function and impact, so hands, feet, scalp and genitals count heavily despite small area; joint symptoms deserve reporting at every appointment; and general health screening is part of psoriasis care rather than separate from it. Anyone describing this as cosmetic is a decade behind the evidence.

• Therapy guidePsoriasis therapy guide
• ToolPsoriatic Arthritis Screen
• QuestionShould I be screened for psoriatic arthritis?
• QuestionWhy am I being told to check my blood pressure and cholesterol?

Calling psoriasis dry skin misses both the mechanism and the stakes. The scale is a consequence of keratinocytes multiplying at several times the normal rate under immune stimulation, not of insufficient moisture, which is why emollients soften and lift the scale without changing the plaque underneath. More importantly, the framing conceals that psoriasis is a systemic inflammatory disease: it is associated with psoriatic arthritis in a large minority, with roughly doubled cardiovascular and metabolic risk, and with substantial rates of depression. Someone treating it as a moisturising problem is not screening for joint disease or having blood pressure and lipids checked. That said, emollients earn a real place — they reduce scale, ease cracking and itching, improve comfort, and help topical treatments penetrate — so the correction is not to abandon them but to recognise they are supportive rather than definitive. The active treatment is anti-inflammatory: vitamin D analogues, topical steroids, phototherapy or systemic drugs, depending on severity.

• Therapy guidePsoriasis therapy guide
• QuestionWhat actually causes psoriasis?
• QuestionWhy am I being told to check my blood pressure and cholesterol?

Diet is where the gap between online claims and evidence is widest. What has support: in people with obesity, weight reduction improves psoriasis severity and improves response to treatment, and that is the single best-evidenced dietary intervention. Some evidence supports a Mediterranean-style eating pattern, plausibly through reduced systemic inflammation. Gluten-free eating benefits those with confirmed coeliac disease or demonstrated gluten sensitivity, which is more common in psoriasis than in the general population, so testing before eliminating is sensible — and pointless for everyone else. What lacks support: nightshade avoidance, dairy elimination in the absence of allergy, juice cleanses, and the various anti-inflammatory protocols sold with supplements attached. The cost of the belief is real, since restrictive diets are expensive, socially isolating and occasionally nutritionally harmful, and they consume attention that effective treatment needs. Alcohol reduction is worth doing on its own evidence. Vitamin D supplementation corrects deficiency but oral vitamin D does not treat psoriasis, despite topical vitamin D analogues working well.

• Therapy guidePsoriasis therapy guide
• QuestionDoes my weight affect psoriasis?
• QuestionDo any supplements help psoriasis?

Genital psoriasis is far more common than its visibility in consultations suggests, affecting a large proportion of people with psoriasis at some point, and it is consistently among the most distressing sites because of the effect on comfort, intimacy and self-image. It usually appears as smooth, well-defined red or violaceous patches without much scale, since the area is moist, and it can be intensely uncomfortable, with fissuring, itch and pain during sex. It is not an infection and it is not a sexually transmitted condition, though it can be mistaken for thrush or a fungal infection and treated ineffectively for months. Treatment is straightforward and specific: mild topical steroids for short courses, calcineurin inhibitors for maintenance, gentle emollients, and avoidance of irritants including fragranced washes. Potent steroids are avoided here. Two things worth doing: raise it explicitly, since clinicians frequently do not ask and it is on the list of sites that justify systemic treatment regardless of area; and use plain fragrance-free products and cotton underwear, which sounds trivial and genuinely helps.

• Therapy guidePsoriasis therapy guide
• QuestionHow do I treat psoriasis on my face or in the folds?
• QuestionMy psoriasis covers a small area — does that mean it's mild?

Scalp psoriasis fails mostly on delivery. Thick adherent scale blocks anything applied over it, and products designed for hair rather than scalp never reach the plaque. The sequence that works: soften and lift scale first, using a salicylic acid preparation, coconut-oil compound ointment or an oil left on for several hours or overnight, then wash it out with a tar or ketoconazole shampoo left in contact for several minutes rather than rinsed immediately. Then apply active treatment directly to the scalp with a nozzle, dropper or foam — a potent topical steroid scalp application, a vitamin D analogue, or the combination products that pair both — parting the hair section by section rather than rubbing it over the top. Formats matter enormously for adherence: foams and solutions are more acceptable than greasy ointments for daytime use, and many people do the messy descaling at weekends. Two extras: scalp psoriasis frequently extends onto the forehead, ears and neck, which needs treating too, and hair loss during a bad phase usually recovers once the scalp settles.

• Therapy guidePsoriasis therapy guide
• QuestionIs this scalp psoriasis or just bad dandruff?
• QuestionShould I pick or scrub the scale off?

Vitamin D analogues — calcipotriol, calcitriol, tacalcitol — bind vitamin D receptors in keratinocytes and normalise their proliferation and differentiation, which directly addresses the mechanism producing scale, while also exerting immune effects. They work more slowly than a steroid and without the thinning risk, which makes them ideal for maintenance. In practice the standard first-line topical for plaque psoriasis is a fixed combination of calcipotriol with betamethasone, available as ointment, gel and foam, which outperforms either component alone: the steroid brings rapid control and the vitamin D analogue sustains it. Typical use is once daily for four weeks or so to gain control, then stepping down to intermittent or vitamin D analogue alone. Practical points: they can irritate, particularly on the face and in the folds, where gentler analogues or other agents are preferred; there is a weekly maximum quantity because of calcium absorption, which matters if you are treating large areas; and they should not be applied at the same moment as salicylic acid, which inactivates them.

• Therapy guidePsoriasis therapy guide
• QuestionHow long can I keep using the steroid?
• QuestionIn what order do I apply everything?

Coal tar has been used for over a century and remains in treatment guidelines because it works: it slows keratinocyte proliferation and has anti-inflammatory and anti-itch effects, with reasonable evidence in plaque and scalp psoriasis. It comes as shampoos, bath additives, creams and stronger preparations used in specialist settings, sometimes combined with phototherapy. Practical realities are what limit it. It smells strongly, stains skin, hair, clothing and bedding, and can cause folliculitis and irritation, so it is applied in the evening onto old nightwear and old sheets, or used as a shampoo left on for several minutes before rinsing. It increases photosensitivity, so sun protection matters during use. Concerns about carcinogenicity from occupational tar exposure have been examined in patients and long-term studies have not shown a clear increase in skin cancer at therapeutic doses. Two suggestions: start with a tar shampoo for scalp involvement, which is the most acceptable format, and treat cosmetic intolerance as a legitimate reason to choose something else rather than a failure of will.

• Therapy guidePsoriasis therapy guide
• QuestionWhat is the right way to treat scalp psoriasis?
• QuestionWhat can I actually buy over the counter?

Facial, flexural and genital psoriasis needs a different approach from a plaque on an elbow, because absorption through thin or occluded skin is far higher and the local side effects of steroids — thinning, stretch marks, visible vessels — appear much faster. Standard practice: mild potency steroids only, for short defined courses; calcineurin inhibitors such as tacrolimus or pimecrolimus, which carry no thinning risk and are widely used off-label at these sites for maintenance; and vitamin D analogues used cautiously, since they irritate thin skin, with gentler members of the class sometimes preferred. Emollient underneath everything. Practical additions: keep the area dry and reduce friction in the folds, since maceration worsens it; watch for secondary candida infection, which is common in flexures and needs its own treatment; and never transfer a body-strength preparation onto the face because you have it in the cupboard. If sensitive-site psoriasis is not controlled, that alone justifies escalation to systemic treatment regardless of how little skin is involved.

• Therapy guidePsoriasis therapy guide
• ToolFTU Calculator
• QuestionWhy are my armpits and groin red but not scaly?
• QuestionCan psoriasis affect the genitals?

The pharmacy tier in psoriasis is real but narrow, and knowing its limits saves months. Emollients are the foundation — used generously they reduce scale, ease cracking and itching, and improve how well prescribed treatments penetrate. Salicylic acid preparations lift adherent scale, which matters because thick scale physically blocks anything applied on top; urea does similar work. Coal tar has genuine evidence going back decades, in shampoos, bath additives and creams; it smells, stains and is cosmetically unpopular, but it works and remains in guidelines. What the shelf cannot do: clear established plaques, treat nail or joint disease, or address the immune process driving any of it. The prescription tier starts with vitamin D analogues such as calcipotriol, usually combined with a potent steroid, and those are the products that actually clear plaques — they are not available over the counter for good reason. Two practical points: descale first, then apply active treatment, and treat over-the-counter products as the supporting layer rather than the attempt.

• Therapy guidePsoriasis therapy guide
• QuestionWhich moisturiser should I use on plaques?
• QuestionWhat do the vitamin D creams actually do?

Nail involvement affects a large share of people with psoriasis and carries information beyond the nails themselves. The characteristic changes are pinprick pitting of the nail plate, yellow-brown oil-drop or salmon-patch discolouration under the nail, onycholysis where the nail lifts from its bed, subungual thickening and crumbling, and splinter haemorrhages. Two things follow. Nail changes are among the strongest predictors of psoriatic arthritis, particularly of the joint nearest the nail, so their presence is a reason to be screened for joint disease rather than a purely cosmetic matter. And nail psoriasis is genuinely difficult to treat topically, because the target sits under a plate that blocks almost everything — options include potent steroid or vitamin D applications to the nail fold, intralesional steroid injections, and systemic treatment, which is where the real responses come from. It also mimics fungal nail infection closely, and the two coexist, so a clipping sent for analysis is worth doing before committing to months of antifungal treatment.

• Therapy guideNail fungus therapy guide
• ToolPsoriatic Arthritis Screen
• QuestionShould I be screened for psoriatic arthritis?
• QuestionCould this be a fungal infection instead?

Sequence matters more in psoriasis than in most conditions because scale physically blocks absorption. A workable order: soften and remove scale first, using a salicylic acid or urea preparation or a soak; apply the active treatment — vitamin D analogue, steroid, or the combination — directly to the plaque; and use emollient generously around and afterwards, allowing time between layers. Practical rules that prevent common mistakes. Salicylic acid inactivates calcipotriol, so they go on at different times of day rather than together. Leave roughly twenty to thirty minutes between an emollient and a medicated product so the active is not diluted or spread onto unaffected skin. Apply treatment to plaques only and emollient everywhere. Wash your hands after applying a potent steroid unless your hands are being treated. And note which products are once daily versus twice — several modern combination products are once daily, and applying them more often wastes medication without benefit. If your regimen has become too complicated to follow, say so; a simpler one that gets done beats an elegant one that does not.

• Therapy guidePsoriasis therapy guide
• ToolRoutine Order
• ToolFTU Calculator
• ReadDoes the Order of Your Skincare Routine Actually Matter?
• QuestionWhat do the vitamin D creams actually do?
• QuestionWhich moisturiser should I use on plaques?

The choice is governed by greasiness and quantity rather than by formulation cleverness. Ointments containing petrolatum or paraffin outperform creams, which outperform lotions, because occlusion softens scale and reduces water loss through a plaque. Apply after bathing while skin is damp, and repeat through the day on hands and anywhere that cracks. Useful additions: urea at 5–10% to soften thick scale, and salicylic acid preparations used specifically for descaling rather than as a daily moisturiser. Fragrance-free is preferable, since plaques are broken skin. Quantities are larger than people expect — widespread psoriasis needs hundreds of grams a week, and running out is a treatment failure rather than an inconvenience, so ask for prescriptions by quantity where emollients are prescribed. Two practical notes: paraffin-based emollients are flammable and soak into fabric, so keep them away from naked flames and cigarettes; and emollient applied before a topical steroid or vitamin D analogue should be given twenty minutes to absorb rather than layered wet.

• Therapy guidePsoriasis therapy guide
• ToolFTU Calculator
• ProductAestura Atobarrier 365 Body Cream
• QuestionWhat can I actually buy over the counter?
• QuestionShould I pick or scrub the scale off?

Plaques improve in a predictable sequence: thickness reduces first, then scale, then area, and colour last — which means a flat brown or pink mark where a plaque used to be is a treated plaque rather than an active one. Judging by redness alone therefore understates progress, and does so most in deeply pigmented skin where residual dyspigmentation is prominent. Better measures. Run your fingers over a representative plaque and note whether it is raised; count involved areas; score itch out of ten; note nights of disturbed sleep. Photograph the same area monthly in consistent light. Formal scores exist and are used in clinics and for funding decisions, and completing quality-of-life questionnaires honestly matters because they influence escalation. Set review points appropriate to the treatment tier rather than checking weekly. Two things worth reporting rather than absorbing: joint pain or morning stiffness, which changes the whole plan, and treatment you have not been using as prescribed, since undisclosed non-use looks identical to treatment failure.

• Therapy guidePsoriasis therapy guide
• ToolPASI Calculator
• ToolProgress Photo Tracker
• ToolItch Scale (0–10)
• QuestionWhy are there marks where the plaques were?
• QuestionHow long before treatment shows anything?

There is no standard duration, and honest answers here are ranges rather than numbers. Guttate psoriasis often resolves within weeks to months and may never return. Chronic plaque psoriasis relapses on a personal rhythm, with many people having a predictable seasonal pattern of winter worsening and summer improvement. What is more predictable is what happens after treatment stops. Topical treatment withdrawn abruptly is commonly followed by return within weeks; stepping down to intermittent maintenance extends the interval substantially. Systemic treatment stopped usually means gradual relapse over weeks to months, with the interval depending on the drug — this is well documented for biologics, where most people relapse within six months of stopping although a minority stay clear far longer. That is why psoriasis treatment is framed as ongoing rather than as a course. Two practical points: use a clear period to step down deliberately rather than stopping outright, and treat early return as a signal to step back up promptly rather than waiting to see how bad it gets.

• Therapy guidePsoriasis therapy guide
• QuestionCan I stop treatment once I'm clear?
• QuestionWhat does long-term maintenance involve?

Expectations differ by tier and mismatching them is why people abandon treatment that is working. Topical steroid and vitamin D combinations typically show visible thinning of plaques within two to four weeks, with full benefit around eight; the vitamin D component works more slowly than the steroid, so early improvement is largely steroid-driven and the maintenance benefit accrues later. Phototherapy usually needs fifteen to thirty sessions over six to twelve weeks before a clear result. Methotrexate takes eight to twelve weeks to show its effect, ciclosporin considerably faster at two to four. Biologics vary by class, with meaningful improvement often by weeks four to eight and the primary assessment point at twelve to sixteen weeks — and some people who look unimpressive at twelve are doing well at twenty-four, which is why prescribers resist switching early. Two things worth doing: photograph a representative area at the start, since gradual thinning is hard to perceive day to day; and note that residual flat brown or pale marks after a plaque resolves are pigment change, not remaining disease.

• Therapy guidePsoriasis therapy guide
• ToolProgress Photo Tracker
• ToolPASI Calculator
• QuestionAm I actually improving?
• QuestionWhy are there marks where the plaques were?

When a plaque resolves it commonly leaves a flat mark, hyperpigmented or hypopigmented depending on your skin and the site, and these can take three to twelve months to fade. They are pigment changes rather than remaining disease, and they are not scars — psoriasis does not scar unless the skin has been damaged by picking or infection. The distinction matters for two reasons. Clinically, treatment is often judged to be failing when it has actually succeeded, and continuing to apply potent steroid to a flat pigmented mark adds risk without benefit — run a finger over it, and if it is not raised, it is not active. Personally, in deeply pigmented skin the dyspigmentation is frequently the more distressing part and many people do not consider treatment successful until it resolves, which is worth saying out loud at an appointment rather than assuming it is not a legitimate concern. What helps is time and sun protection, since ultraviolet exposure deepens the contrast. What does not help is more steroid.

• Therapy guidePsoriasis therapy guide
• ToolSunscreen Finder
• QuestionWhy do the marks left behind bother me more than the plaques?
• QuestionAm I actually improving?

Escalation criteria are more generous than most people assume, and waiting is common. The usual triggers: topical treatment used correctly for eight to twelve weeks without adequate control; involvement of the scalp, face, hands, feet, nails or genitals, which counts as severe regardless of how little skin is involved; extensive disease by area; any psoriatic arthritis, which changes the treatment choice entirely; and substantial impact on work, sleep, relationships or mood, which is an explicit criterion in guidelines rather than an emotional aside. The next tier is usually phototherapy where accessible, then conventional systemic drugs such as methotrexate or ciclosporin, then biologics — with most funding systems requiring documented failure of prior steps. Two things that delay escalation unnecessarily: not mentioning special-site involvement, particularly genital and scalp, and stoicism on quality-of-life questionnaires. Answer those honestly. Two things that speed it: a clear record of what you have used and for how long, and photographs from a bad period.

• Therapy guidePsoriasis therapy guide
• ToolPASI Calculator
• ToolDerm Visit Prep
• QuestionMy psoriasis covers a small area — does that mean it's mild?
• QuestionWhat gets me access to a biologic?

A flare on treatment has explanations worth working through in order. Infection is the most frequent, especially streptococcal throat infection. New medications, particularly beta-blockers, lithium and antimalarials, or a course of oral steroids that has been stopped. Adherence, which is uncomfortable to raise and extremely common — topical regimens are burdensome and drift is normal rather than shameful. Weight change, since some biologics are dosed by weight. Loss of response to a biologic, which happens through antibody formation over time and is a recognised reason to switch within or between classes. And paradoxical psoriasis, where a drug given for another condition — a TNF inhibitor prescribed for inflammatory bowel disease or arthritis — provokes psoriasis, which is well described and needs the prescribing team involved. What to do: report it rather than waiting for the next scheduled appointment, mention any infection or new medication in the preceding two months, and be honest about missed doses, since the alternative is escalation you may not need.

• Therapy guidePsoriasis therapy guide
• ToolSkin Flare Diary
• QuestionCan my other medications be making it worse?
• QuestionWhat happens if a biologic stops working?

Winter worsening affects most people with psoriasis and has several converging causes. Ultraviolet exposure falls, removing the natural immunosuppressive effect that improves plaques in summer. Cold outdoor air holds little moisture and indoor heating dries it further, so skin cracks and scale thickens. Illness and infection are commoner, and streptococcal infection in particular triggers flares. Hot baths taken for comfort strip the barrier further. Planning beats reacting: increase emollient quantity and richness before the season rather than after the flare, keep the house humidified if the air is dry, lower shower temperature, and have your treatment in the house rather than needing a prescription in December. If your pattern is severe and predictable, that is a reasonable argument for a winter course of phototherapy, which many services run seasonally for exactly this reason. Two additions: a minority have the opposite pattern with summer worsening, which is real and worth respecting; and holidays in sunnier climates genuinely help, though sunburn triggers Koebner plaques so the exposure needs to be gradual.

• Therapy guidePsoriasis therapy guide
• ToolSkin Flare Diary
• ReadYour Skin Doesn't Need a Whole New Autumn Routine — It Needs About Three Tweaks
• QuestionDoes sunlight genuinely help psoriasis?
• QuestionWhat is light treatment actually like?

Biologics target specific cytokines rather than suppressing immunity broadly, which is why their safety profile is better than older systemic drugs and why long-term registry data have been broadly reassuring. The main consideration is infection: reactivation of latent tuberculosis and hepatitis B is why screening is mandatory before starting, and serious infections are somewhat more common than in untreated populations though less so than with conventional immunosuppressants. Class-specific points matter. TNF inhibitors carry the most historical data and additional cautions around heart failure and demyelinating disease. IL-17 inhibitors can worsen inflammatory bowel disease and are associated with candida infections. IL-23 inhibitors have a particularly clean profile in the data so far. Live vaccines are avoided while on treatment, so vaccination status is brought up to date beforehand. Malignancy risk has not shown a clear increase in current data. What is often left out of the risk conversation: untreated moderate-to-severe psoriasis carries its own cardiovascular and metabolic risk, so the comparison is not against zero.

• Therapy guidePsoriasis therapy guide
• ToolDerm Visit Prep
• QuestionWhich biologic is the best one?
• QuestionWhich vaccines can I have on psoriasis treatment?

The two forms of phototherapy have different risk profiles and conflating them causes unnecessary alarm. PUVA — psoralen plus UVA — has clear evidence of a dose-related increase in squamous cell carcinoma and, at high cumulative exposures, melanoma, which is why it is used far less now and why lifetime session counts are recorded. Narrowband UVB, the standard modern treatment, has not shown a clear increase in skin cancer at the exposures used in ordinary courses, though the follow-up data are not as long as anyone would like, and departments still track cumulative sessions across your lifetime and factor them into decisions about repeat courses. Practical points: eyes are shielded, genitals covered, and photosensitising medications must be declared. Previous PUVA affects later decisions about ciclosporin, which raises skin cancer risk in that group. Skin checks are worth having if you have had substantial phototherapy. Against all this sits the alternative — untreated moderate psoriasis has its own considerable costs, and phototherapy remains an effective, non-systemic option.

• Therapy guidePsoriasis therapy guide
• ToolSkin Cancer Risk Tier
• QuestionWhat is light treatment actually like?
• QuestionSunlight helps — should I use a sunbed?

Potent topical steroids clear plaques quickly and are meant to be used in defined bursts rather than indefinitely. A common pattern is once-daily application of a potent steroid or a steroid–vitamin D combination for around four weeks, then stepping down: alternate days, weekends only, or continuing the vitamin D analogue alone as maintenance, which is where much of the long-term benefit sits. Reasons for the limits are local rather than systemic in most cases — skin thinning, stretch marks and visible vessels with prolonged use, particularly on the face, folds and genitals — plus tachyphylaxis, where the response diminishes with continuous use. There is also a specific risk in psoriasis: abrupt withdrawal after prolonged potent use can precipitate a rebound flare, occasionally pustular, so stepping down is preferable to stopping. Practical points: use a fingertip-unit measure rather than guessing, apply to plaques only, and if you find yourself needing daily potent steroid for months, that is a signal for escalation rather than continuation.

• Therapy guidePsoriasis therapy guide
• ToolFTU Calculator
• QuestionWhat do the vitamin D creams actually do?
• QuestionWhy won't they give me steroid tablets for a bad flare?

Most biologics for psoriasis are given as subcutaneous injections using a pre-filled pen or syringe, taught by a nurse and then done at home. Frequency varies widely by drug — from weekly or fortnightly to every eight or twelve weeks after a loading phase — and that interval is often a significant factor in choosing between them. Practicalities that matter more than people expect: they are stored in a fridge and should be brought to room temperature for twenty to thirty minutes before injecting, which reduces stinging considerably; sites are rotated between thigh and abdomen, avoiding plaques; and a sharps bin and disposal arrangement is provided. Injection-site reactions — redness, mild swelling, itching — are common early and usually settle. For travel, you need a cool bag, a letter for airport security if carrying needles, and planning around the dosing schedule. Home delivery services handle supply in many systems. Two useful notes: fear of self-injection is common and usually resolves after the first few, and if you consistently forget, a longer-interval drug may suit you better.

• Therapy guidePsoriasis therapy guide
• QuestionWhich biologic is the best one?
• QuestionWhat does travelling with psoriasis treatment involve?

Testing is about safety rather than diagnosis, and the schedule depends on the drug. Before starting any systemic treatment expect a baseline panel: full blood count, liver and kidney function, and for biologics, screening for tuberculosis and hepatitis B and C, sometimes HIV. On methotrexate, monitoring is regular — commonly every two to four weeks initially, then every one to three months — checking blood counts and liver function, with a liver fibrosis marker used in some systems. Ciclosporin requires kidney function and blood pressure monitoring, the latter at every visit. Acitretin needs lipids and liver function, plus pregnancy testing. Most biologics require less frequent monitoring once established, often annually with periodic tuberculosis reassessment depending on local practice. Alongside all of this, psoriasis itself warrants periodic checks of blood pressure, glucose, HbA1c and lipids given the raised cardiometabolic risk, which is a separate reason for blood tests and frequently overlooked. Two practical points: keep your own record of results, and never skip monitoring because you feel well, since the risks being watched for are silent.

• Therapy guidePsoriasis therapy guide
• ToolDerm Visit Prep
• QuestionWhat is methotrexate like to take?
• QuestionWhy am I being told to check my blood pressure and cholesterol?

Secondary loss of response is a recognised phenomenon rather than a failure. Over months or years, some people develop anti-drug antibodies that neutralise the biologic, and response fades; others lose effect for reasons that are less clear. It is more frequent with some older agents than newer ones, and concurrent methotrexate is sometimes used to reduce antibody formation. What happens next is straightforward in principle: switching within the same class sometimes works, switching to a different mechanism — from a TNF inhibitor to an IL-17 or IL-23 agent, for instance — more often does, and the modern range means several options usually remain. Before switching, prescribers will usually check the obvious confounders: missed doses, weight change affecting weight-based dosing, infection, a new medication, or drug storage problems. Two things worth doing: report declining response early rather than waiting until you are back to baseline, since switching from a partial response is easier to justify than from a full relapse, and keep a record of which drugs you have had and how each performed.

• Therapy guidePsoriasis therapy guide
• QuestionWhich biologic is the best one?
• QuestionWhy did I flare while on treatment?

Two separate considerations. Pharmacologically, methotrexate is the drug where alcohol matters most, since both affect the liver and the combination raises the risk of liver injury — most clinicians advise limiting intake substantially rather than prohibiting it, and being honest about your actual consumption so monitoring can be set appropriately. Acitretin carries similar liver and lipid considerations, plus an absolute rule for anyone who could become pregnant: alcohol converts acitretin into a longer-lived compound, which is why pregnancy avoidance extends for years after stopping. Ciclosporin has fewer direct interactions but adds to cardiovascular load. Biologics have no meaningful alcohol interaction. Separately from any drug, alcohol worsens psoriasis itself, is associated with more severe disease and poorer treatment response, and contributes to the cardiovascular risk psoriasis already raises. Two practical points: your prescriber needs an accurate figure rather than a diplomatic one, and if drinking is difficult to reduce, saying so opens the door to support rather than judgement.

• Therapy guidePsoriasis therapy guide
• QuestionWhat is methotrexate like to take?
• QuestionHow much do smoking and drinking affect psoriasis?

The evidence is thin. Fish oil and omega-3 supplementation appear in guideline reviews of alternative modalities with limited supporting data and modest effects. Oral vitamin D is worth correcting if you are deficient, which is common in psoriasis, but supplementing beyond correction does not treat the disease — despite topical vitamin D analogues working well, which is a source of understandable confusion, since the topical acts locally at high concentration. Turmeric and curcumin have small studies. Selenium, zinc and B12 lack support. What deserves caution rather than indifference: herbal preparations can interact with methotrexate and ciclosporin or independently affect the liver, St John's wort induces enzymes that alter drug levels, and creams sold as herbal have repeatedly been found to contain undeclared potent steroids. Two practical points. Tell whoever manages your treatment what you take, since supplements rarely get mentioned and interactions are real. And weigh the spend: the money involved often exceeds the cost of the treatments with actual evidence behind them.

• Therapy guidePsoriasis therapy guide
• ToolIngredient Decoder
• QuestionDo natural treatments work for psoriasis?
• QuestionWill changing my diet clear psoriasis?

Hair dye on inflamed, cracked scalp skin stings considerably and increases absorption of the chemicals, so the practical rule is to treat the psoriasis first and colour a settled scalp. Perform the manufacturer's allergy alert test regardless, since paraphenylenediamine is a common sensitiser and psoriatic scalp skin is more permeable. Tell the salon in advance: some will decline to work on an actively scaling scalp, which is usually about their own uncertainty rather than any real transmission risk, and a brief explanation that psoriasis is not contagious sometimes resolves it — in many places refusing service for a long-term health condition may also be unlawful. Practical adaptations: ask them to skip vigorous scalp massage, which can Koebnerise; request a barrier along the hairline; use lukewarm rather than hot water; and schedule colouring away from your descaling routine, since salicylic acid preparations and dye do not mix well. Bleach and relaxers are harsher and worth avoiding while plaques are active.

• Therapy guidePsoriasis therapy guide
• ToolPatch Test Log
• QuestionWhat is the right way to treat scalp psoriasis?
• QuestionWhat do I do if I'm refused service because of my skin?

Psoriasis does not rule out a skincare routine, and the constraints are localised. On unaffected skin, retinoids, vitamin C, exfoliating acids and the rest can be used as normal. On or immediately around plaques the calculation changes: broken, fissured skin absorbs more and irritates easily, and irritation itself can provoke new psoriasis at the site. Exfoliating acids are the interesting exception — salicylic acid is used deliberately in psoriasis to lift scale, so a low-strength product may be useful rather than harmful, while glycolic and lactic acids can help or sting depending on the plaque. Retinoids applied to plaques are generally irritating and offer little, though topical tazarotene is a prescribed retinoid used in psoriasis specifically. Two rules keep it simple: introduce one thing at a time and treat any sustained stinging as a stop signal, and keep prescribed psoriasis treatments and cosmetic actives at different times of day so a reaction can be attributed. Sunscreen is compatible with everything and worth wearing.

• Therapy guidePsoriasis therapy guide
• ToolConflict Checker
• ToolRoutine Order
• QuestionIn what order do I apply everything?
• QuestionShould I pick or scrub the scale off?

Raise it weeks ahead rather than at the pre-operative check. Biologics are commonly held around surgery because of infection and wound-healing considerations, with the pause typically timed relative to the dosing interval rather than a fixed number of days, and resumed once the wound is healed and no infection is present. Methotrexate and ciclosporin decisions vary — methotrexate is often continued for minor surgery and paused for major procedures. Topicals continue, though nothing goes on the surgical site on the day. Practical extras specific to psoriasis: surgical incisions can provoke new plaques at the site through the Koebner phenomenon, which is worth expecting rather than being alarmed by; and a flare during the treatment pause is common, so agree in advance what to use if that happens. Two things to bring to the pre-operative assessment: the exact name and dosing schedule of your drug, and the contact for your dermatology team, since surgical teams often want to confirm the plan with them rather than decide alone.

• Therapy guidePsoriasis therapy guide
• ToolDerm Visit Prep
• QuestionAre biologics safe to be on long term?
• QuestionWhat sets off a psoriasis flare?

The specific risk is the Koebner phenomenon: psoriasis appearing at sites of skin trauma, which a tattoo or piercing certainly is. Estimates vary but a meaningful proportion of people with psoriasis Koebnerise, and a new plaque developing within a tattoo is both disfiguring to the artwork and difficult to treat. Sensible precautions if you proceed: only on clear, well-controlled skin, never over or near an existing plaque, on a site that is not a usual location for your psoriasis, with a reputable artist who is told about the condition — many will decline to work over active disease, which is appropriate rather than discriminatory. Aftercare matters more than usual, since infection compounds everything. Two additional considerations: if you are on immunosuppressive treatment, infection risk is higher and the timing should be discussed with your team; and while tattoo ink allergy is uncommon, reactions are harder to manage on psoriatic skin. Piercings carry the same Koebner risk plus a longer healing period, and earlobes and navels are common sites for it.

• Therapy guidePsoriasis therapy guide
• QuestionWhat sets off a psoriasis flare?
• QuestionShould I pick or scrub the scale off?

The rule is straightforward once the categories are clear. Non-live vaccines — influenza, COVID, pneumococcal, most travel vaccines, shingles in its recombinant form — are safe on all psoriasis treatments and are actively recommended, since immunosuppressed people benefit most from them. Live vaccines, including MMR, yellow fever, live shingles, oral typhoid and BCG, are avoided while on biologics, methotrexate, ciclosporin and other immunosuppressants. That is why vaccination status is reviewed before starting systemic treatment: bringing everything up to date in advance, including shingles vaccination where appropriate, avoids the problem entirely. Timing matters, since live vaccines generally need to be given several weeks before starting treatment. Two practical points. Tell any clinician offering a vaccine what you take, since a skin condition rarely prompts the question. And if you are travelling somewhere requiring yellow fever vaccination, raise it early — the alternatives are limited and the planning window is weeks, not days. Household members can have live vaccines normally, with minor precautions in a few cases.

• Therapy guidePsoriasis therapy guide
• QuestionAre biologics safe to be on long term?
• QuestionWhat does travelling with psoriasis treatment involve?

A biosimilar is a version of an existing biologic manufactured after the original patent expires, approved only after demonstrating no clinically meaningful difference in structure, efficacy, safety and immunogenicity. Studies of switching from an originator to a biosimilar in psoriasis have not shown loss of efficacy or increased adverse events, and health systems switch patients routinely because the cost saving is substantial — money that funds treating more people. What people notice in practice is usually the delivery device rather than the drug: a different pen, a different injection technique, sometimes a different injection frequency of the same molecule, which is worth being shown rather than working out alone. Some report more injection-site stinging with a particular formulation. A nocebo effect is well described, where expecting a worse result produces reported symptoms, which is worth knowing without dismissing genuine problems. Two reasonable things to ask: to be trained on the new device, and what happens if your disease genuinely deteriorates after the switch, since switching back is possible where clinically justified.

• Therapy guidePsoriasis therapy guide
• QuestionWhat is injecting a biologic actually like?
• QuestionWhat happens if a biologic stops working?

Ciclosporin's value is speed. It suppresses T-cell activation directly and can bring a severe flare under control within two to four weeks, faster than any other systemic option, which makes it the choice for erythrodermic or unstable disease and for bridging to a slower-acting treatment. The constraint is cumulative toxicity: it raises blood pressure and can cause progressive, sometimes irreversible kidney impairment, so treatment is generally limited to courses of up to a year and often much less, with blood pressure and kidney function monitored at every visit. It also raises the risk of skin cancer, particularly in people with previous PUVA exposure, and interacts with many drugs including some antibiotics, statins and grapefruit juice. Gum overgrowth and increased body hair are common cosmetic effects. What follows practically: expect it to be a defined bridge rather than a long-term plan, expect frequent monitoring, declare every other medication and supplement you take, and expect relapse fairly quickly after stopping unless something else is in place.

• Therapy guidePsoriasis therapy guide
• QuestionWhat blood tests will I need, and how often?
• QuestionWhen is widespread redness an emergency?

Psoriasis has one of the most active drug development pipelines in medicine, which means trials are frequently recruiting and they are a legitimate route to treatment for two groups: people who have failed several approved options, and people for whom funding criteria block access to a drug that would suit them. What participation typically involves: detailed screening, more frequent monitoring than routine care, a randomised allocation that may include placebo for a defined period, and travel to a trial centre. The monitoring is often the underrated benefit, since trial patients are seen more closely than standard care allows. What to weigh: the placebo possibility and its duration, whether you continue treatment afterwards if the drug works, travel burden, and whether the trial drug's mechanism differs from what has already failed you. Ask your dermatologist directly whether any trials are recruiting locally and whether you would be eligible — this is rarely offered unprompted. National psoriasis charities also maintain trial listings, and registries are publicly searchable.

• Therapy guidePsoriasis therapy guide
• ToolDerm Visit Prep
• QuestionWhat if nothing has worked?
• QuestionWhat gets me access to a biologic?

Psoriasis treatment is layered rather than sequential. Topicals continue alongside systemic treatment in most people, because near-complete clearance still leaves a few stubborn plaques and treating those topically is easier than escalating the systemic dose. Phototherapy combines well with acitretin, allowing lower doses of both, and with topicals. Methotrexate is sometimes continued alongside a biologic, particularly with TNF inhibitors, to reduce anti-drug antibody formation. Scalp, nail and genital disease frequently need their own targeted treatment regardless of what is happening systemically. What is generally avoided: combining ciclosporin with phototherapy, given skin cancer risk, and stacking multiple immunosuppressants without clear reason. Two practical points. Ask explicitly what each element is meant to be doing, since people frequently stop their topicals once a biologic starts and then attribute residual plaques to the biologic failing. And say if the combined regimen has become unmanageable — a simpler plan that gets followed usually outperforms a comprehensive one that does not.

• Therapy guidePsoriasis therapy guide
• ToolConflict Checker
• QuestionIn what order do I apply everything?
• QuestionWhich biologic is the best one?

Several oral options exist and needle aversion is a legitimate reason to ask. The older systemics — methotrexate, ciclosporin and acitretin — are all tablets, with the monitoring and constraints described elsewhere. Apremilast is a phosphodiesterase-4 inhibitor taken twice daily, with a favourable safety profile requiring no routine blood monitoring, which is its main attraction; its clearance rates are lower than biologics, and diarrhoea, nausea, headache and weight loss are common early and usually settle. Newer oral agents targeting the IL-23 pathway have emerged, offering efficacy closer to injectable biologics in tablet form, though availability and funding vary considerably by country. Oral JAK inhibitors are used in psoriatic arthritis and carry class warnings around cardiovascular events, clots and malignancy. What to ask: whether an oral option achieving the clearance you need is available and funded where you are, since the trade is usually efficacy or cost against convenience. Two notes: apremilast is a reasonable choice where immunosuppression is a concern, and daily tablets suit some people far better than a fridge and a needle.

• Therapy guidePsoriasis therapy guide
• QuestionWhich biologic is the best one?
• QuestionWhat is injecting a biologic actually like?

Treatment goals in psoriasis have shifted substantially, and knowing the current standard matters because it determines whether you accept a partial result. A generation ago, a 75% reduction in severity was the trial benchmark and a reasonable clinical aim. With modern biologics, 90% or complete clearance is achieved by a large proportion of people, and consensus targets have moved accordingly — commonly expressed as reaching minimal residual disease within a defined period, with a review point if that is not met. Alongside the skin score sits a quality-of-life threshold, since some people with limited skin involvement are severely affected and vice versa. What this means for you: if you have been on the same treatment for years with plaques you have simply learned to live with, that is worth revisiting rather than accepting, particularly if you have not been assessed since newer options became available. Two useful questions at an appointment: what is the target for me, and by when should we know whether this treatment has reached it.

• Therapy guidePsoriasis therapy guide
• ToolPASI Calculator
• QuestionWhen should treatment be stepped up?
• QuestionWhich biologic is the best one?

Genuine multi-drug-resistant psoriasis exists but is less common than apparent failure. Work through the possibilities in order. Diagnosis: cutaneous T-cell lymphoma, tinea, and some drug eruptions imitate psoriasis and do not respond to it, and a biopsy is reasonable if nothing has ever worked. Adherence: topical regimens are burdensome and drift is normal — being honest about it changes the plan more usefully than escalating on false premises. Dose and duration: a treatment stopped at eight weeks that needed sixteen was never given a chance. Provocations: an unrecognised medication, ongoing streptococcal infection, smoking, or oral steroids. Only then is it true treatment resistance, and even then the modern landscape offers several distinct mechanisms — if a TNF inhibitor failed, an IL-17 or IL-23 agent may still work well, and cycling classes is standard practice rather than a last resort. Two things worth asking for at that point: a second opinion at a specialist psoriasis centre, and consideration of clinical trials, which are often accessible and rigorous.

• Therapy guidePsoriasis therapy guide
• ToolDerm Visit Prep
• QuestionWhat happens if a biologic stops working?
• QuestionWhat tests will confirm psoriasis?

Narrowband UVB is delivered in a whole-body cabinet, with exposure starting at seconds and building gradually — usually still under ten minutes at the top of a course. Eyes are protected with goggles and genitals covered, and the dose is calculated from your skin type and increased incrementally. Sessions run two or three times a week, and a course of fifteen to thirty treatments over eight to twelve weeks is typical, with improvement usually visible from around the third or fourth week. Emollients are applied beforehand in some protocols and avoided in others, since some block the light, so follow the department's instruction. Side effects during a course are mild for most people: redness like light sunburn if the dose advances too quickly, dryness, itch early on, and occasionally provoked cold sores. What limits it is logistics rather than tolerability — attending a hospital two or three times weekly for three months is genuinely difficult around work and childcare, and that is why courses get abandoned. Ask about appointment times and home units before committing.

• Therapy guidePsoriasis therapy guide
• QuestionDoes light treatment raise my skin cancer risk?
• QuestionSunlight helps — should I use a sunbed?

Modern biologics fall into classes with different profiles, and choosing among them is a matching exercise rather than a ranking. IL-23 inhibitors deliver high clearance rates with infrequent dosing — often every eight or twelve weeks after loading — and a notably clean safety profile. IL-17 inhibitors work quickly and clear skin very effectively, and also treat psoriatic arthritis, but can worsen inflammatory bowel disease and carry a candida signal. TNF inhibitors have the longest track record, treat joints well, and carry more cautions around heart failure and demyelinating disease. What tips the decision: whether you have psoriatic arthritis, since that narrows the field to agents effective for joints; inflammatory bowel disease, which rules out IL-17 agents; pregnancy plans; how often you want to inject; and, unavoidably, what your health system funds, which frequently determines the sequence more than clinical preference does. Two practical points: ask why a particular agent was chosen for you, and mention any bowel symptoms, joint symptoms or pregnancy plans before the decision rather than after.

• Therapy guidePsoriasis therapy guide
• ToolDerm Visit Prep
• QuestionAre biologics safe to be on long term?
• QuestionShould I be screened for psoriatic arthritis?

The direct drug costs are frequently the smallest part. Emollients, coal tar, salicylic acid preparations and generic topical steroids are inexpensive, and vitamin D combination products are usually prescribed rather than bought. Biologics are extraordinarily expensive at list price and are essentially always funded by health systems or insurers rather than paid privately, which is why the access criteria exist. Where money actually goes for individuals: emollient in the quantities psoriasis needs, if it is not prescribed; specialist shampoos and descaling products; laundry, given tar staining and emollient on bedding; time off work for phototherapy two or three times weekly, which is a real and rarely counted cost; and the accumulated spend on unproven creams, supplements and diets, which frequently exceeds everything else combined. Two ways to reduce it legitimately: ask for emollients and scalp preparations on prescription by quantity where that is available, and stop buying anything not on your treatment plan for three months while you run the plan properly.

• Therapy guidePsoriasis therapy guide
• ToolDupe Finder
• QuestionWhich moisturiser should I use on plaques?
• QuestionDo any supplements help psoriasis?

Primary care manages a large share of psoriasis competently, prescribing emollients, vitamin D analogues, steroid combinations, coal tar and scalp preparations. Referral earns its place in several situations: topical treatment failing after a fair trial; involvement of the face, scalp, hands, feet, nails or genitals; extensive disease; any joint symptoms, which should trigger rheumatology involvement; guttate or unstable disease; diagnostic uncertainty; and consideration of phototherapy or systemic treatment, which are specialist-initiated. Erythrodermic or pustular presentations are urgent referrals rather than routine ones. What makes a referral effective: a documented treatment history with durations, photographs from a bad period, a note of impact on work and sleep, and explicit mention of joint symptoms and special sites. Two things that commonly delay it — not mentioning genital or scalp involvement out of embarrassment, and understating impact. Neither serves you. If a referral is declined and your psoriasis is not controlled, ask what threshold would change that.

• Therapy guidePsoriasis therapy guide
• ToolDerm Visit Prep
• ToolPsoriatic Arthritis Screen
• QuestionWhen should treatment be stepped up?
• QuestionShould I be screened for psoriatic arthritis?

Home narrowband UVB is provided in several health systems for people who need repeated courses and cannot attend hospital two or three times weekly, and evidence supports it as comparable in effectiveness to hospital treatment when properly supervised. What proper supervision means: a unit supplied through a dermatology service, an initial dose calculated for your skin type, a written escalation schedule, session logging, goggles, and periodic review with cumulative dose tracked across your lifetime. Handheld units exist for localised disease such as scalp or hands. What is not the same thing: buying an unregulated lamp or a tanning unit online, where the wavelength may be wrong, the dose uncontrolled, and burns or cancer risk unmanaged. Ask specifically whether home phototherapy is available locally, since it is often not offered proactively and the attendance burden is the main reason courses fail. Two considerations: it requires space for a cabinet or panel, and it is not suitable for everyone — photosensitive disease, certain medications and a history of skin cancer all change the calculation.

• Therapy guidePsoriasis therapy guide
• QuestionWhat is light treatment actually like?
• QuestionSunlight helps — should I use a sunbed?

Access turns on documentation rather than on how bad it feels. Most systems require a combination of a validated severity score above a threshold, a quality-of-life measure showing significant impact, and evidence that you have failed, not tolerated, or have a contraindication to standard treatments — usually phototherapy plus at least one conventional systemic such as methotrexate. Some allow faster access for special-site disease or psoriatic arthritis. Three things help. Keep a record of everything tried, with doses and durations, since reconstructing five years of treatment inside one appointment produces a weak application. Attend the assessment during a bad period if you can, because scores are recorded on the day. And complete quality-of-life questionnaires honestly rather than stoically — understating the impact is the commonest reason people fail to qualify, and joint symptoms, sleep loss and work absence all count. If you are told you do not meet criteria, ask precisely which criterion is not met, since that tells you what would need to change.

• Therapy guidePsoriasis therapy guide
• ToolPASI Calculator
• ToolDerm Visit Prep
• ToolProgress Photo Tracker
• QuestionWhen should treatment be stepped up?
• QuestionMy psoriasis covers a small area — does that mean it's mild?

Two separate needs arise. Treatment time: phototherapy requires attendance two or three times weekly for months, and appointments for monitoring and reviews recur, which is difficult around inflexible hours. Symptom-related needs: joint pain and stiffness with psoriatic arthritis, discomfort from cracked hands in manual work, uniforms that irritate, and the fatigue that accompanies inflammatory disease. In many jurisdictions a long-term condition with substantial impact may qualify for legal protection and a duty on employers to consider reasonable adjustments — flexible hours to attend treatment, changes to uniform or PPE, modified duties during a flare. Occupational health referral is the usual route and is worth asking for rather than waiting to be offered. Practical suggestions: get a supporting letter from your clinician describing the treatment schedule rather than the diagnosis alone, since employers respond better to a concrete requirement; and raise it before performance becomes an issue. Two things worth knowing: you generally do not have to disclose a diagnosis to colleagues, and hand involvement in wet or manual work may itself be a workplace matter.

• Therapy guidePsoriasis therapy guide
• QuestionWhat is light treatment actually like?
• QuestionWhat do I do if I'm refused service because of my skin?

Appointments are short and the information that changes decisions rarely gets volunteered. Bring five things. A treatment list: what you used, how much, for how long, and what happened, since inadequate duration explains many apparent failures. Photographs from a bad period, because appointments have a habit of landing on good days. Joint symptoms specifically — pain, swelling, morning stiffness over thirty minutes, heel pain, swollen fingers or toes — since psoriatic arthritis is the thing most often missed. Special sites, meaning scalp, nails, hands, feet and genitals, which count as severe regardless of area and which people routinely omit. And impact: sleep lost, work affected, activities avoided, mood. Add your questions in writing. Two closing questions worth asking every time: what should improve and by when, and what happens if it does not. And say plainly if you have not been using something as prescribed — undisclosed non-use looks identical to treatment failure and leads to escalation you may not need.

• Therapy guidePsoriasis therapy guide
• ToolDerm Visit Prep
• ToolProgress Photo Tracker
• ToolPsoriatic Arthritis Screen
• QuestionShould this be managed by my GP or a specialist?
• QuestionWhat gets me access to a biologic?

The relationship is less studied than in some conditions, but the pattern reported clinically and in surveys is that psoriasis frequently worsens around menopause. Plausible mechanisms include falling oestrogen — which is also the likeliest explanation for why many women improve during pregnancy, when oestrogen is high — alongside age-related skin dryness, sleep disruption, and the metabolic changes of midlife that overlap with psoriasis comorbidities. Practically, the adjustments are unglamorous: richer emollients used more often, since drier skin cracks and scales more; attention to the cardiometabolic picture, which matters more at this stage and is already elevated by psoriasis; and a lower threshold for reviewing treatment rather than assuming a worsening is inevitable. Whether hormone replacement helps psoriasis specifically is not established, and it is a broader decision, but skin changes are legitimate to mention among your symptoms. Two things worth checking if psoriasis worsens sharply in midlife: new medications, and joint symptoms, since psoriatic arthritis onset commonly falls in this age range.

• Therapy guidePsoriasis therapy guide
• QuestionWhy am I being told to check my blood pressure and cholesterol?
• QuestionShould I be screened for psoriatic arthritis?

Topical treatment during lactation is usually straightforward, with emollients unrestricted and topical steroids considered compatible, applied away from the breast and nipple or wiped off before feeding so the infant does not contact them directly. Vitamin D analogues and coal tar are used more cautiously and not on the breast. Among systemics, methotrexate and acitretin are avoided during breastfeeding. Ciclosporin transfers into milk and is generally avoided though sometimes used with monitoring. Biologics are large molecules poorly absorbed from an infant's gut and are increasingly regarded as compatible with breastfeeding, with certolizumab having particularly favourable data, though positions vary between guidelines so this is a conversation rather than an assumption. Phototherapy is compatible. Two practical points specific to this period. Psoriasis frequently flares postpartum, sometimes substantially, so having a plan in place before delivery is worth doing. And nipple and areolar psoriasis occurs, is painful during feeding, and is treatable with short courses of mild topical steroid applied after feeds.

• Therapy guidePsoriasis therapy guide
• ToolPregnancy-Safe Checker
• QuestionHow is psoriasis treated during pregnancy?
• QuestionWhat do I need to change before trying to conceive?

A short written note covering four things prevents most problems. That psoriasis is not contagious, which pre-empts exclusion from swimming, PE and shared activities — exclusion still happens and has no medical basis. That treatment may need applying during the day, with permission and storage arranged in writing, since many schools require this formally. That certain activities may need adjusting during a flare: swimming in heavily chlorinated pools can sting cracked plaques, and PE kit rules may need flexibility to allow longer sleeves if your child prefers. And that visible plaques and shedding scale attract questions and sometimes bullying, which is a safeguarding matter rather than something for a child to manage alone. Two additions. Give your child their own sentence to use when asked, since being asked repeatedly without an answer ready is where the self-consciousness sets in. And if psoriasis is affecting school attendance, participation or mood, say so at medical appointments — impact on a child's education is a legitimate factor in escalating treatment, and paediatric psoriasis is under-treated more often than over-treated.

• Therapy guidePsoriasis therapy guide
• QuestionHow is psoriasis treated in children?
• QuestionCan psoriasis spread to other people?

Psoriasis in children is common enough to be unremarkable, often beginning as guttate disease after a throat infection, and it is frequently misdiagnosed as eczema or fungal infection. Treatment follows adult principles with adjustments. Emollients and topical steroids at potencies appropriate to the child's age and the site come first, with vitamin D analogues used alongside; coal tar preparations are still used. Phototherapy is possible for older children who can cooperate with a cabinet. Systemic options exist and several biologics now carry paediatric licences, which has changed the outlook for severe childhood disease considerably; methotrexate remains widely used. Two considerations specific to children. Growth, weight and cardiovascular risk factors are monitored, since childhood psoriasis carries the same metabolic associations and obesity is more common in affected children. And the psychological and school impact deserves explicit attention — bullying, avoidance of swimming and PE, and reluctance to undress are common and are legitimate reasons to escalate treatment. Ask about paediatric dermatology rather than managing severe childhood psoriasis in general practice.

• Therapy guidePsoriasis therapy guide
• QuestionWhat are these sudden small drop-shaped spots?
• QuestionWhat should school know about my child's psoriasis?

Psoriasis has two typical onset peaks, one in the teens to thirties and a later one after fifty, and people who have had it for decades often find it becomes more stable but harder to treat around. Several things shift with age. Kidney function declines, which constrains ciclosporin. Polypharmacy increases the chance that a medication is contributing — beta-blockers and lithium in particular — and interaction risk rises. Infection risk with immunosuppressive treatment is higher, so biologic choice takes comorbidities into account, and vaccination becomes more important. Skin is drier and thinner, so emollient needs rise and steroid side effects appear faster. Practical difficulties matter too: applying treatment to a back or lower legs becomes hard with reduced mobility or arthritis, and phototherapy attendance may be impractical. Two things worth raising: whether anyone can help with application, since untreated areas are often simply unreachable rather than neglected; and cardiovascular risk, which is elevated by psoriasis and compounds with age, making blood pressure, lipids and glucose part of skin care rather than separate from it.

• Therapy guidePsoriasis therapy guide
• QuestionWhy am I being told to check my blood pressure and cholesterol?
• QuestionCan my other medications be making it worse?

Adolescence changes psoriasis in three ways. Biologically, disease can extend or intensify, and guttate flares after throat infections are common in this age group. Practically, responsibility for treatment shifts from parent to teenager, and this is the point at which greasy ointments, tar preparations and multi-step scalp routines get abandoned — surveys consistently find adherence poorest here, and the reasons are entirely rational rather than lazy. Socially, visible plaques and scalp shedding land during the years when appearance carries most weight, affecting swimming, sport, relationships and confidence. What helps: simplifying the regimen to what will actually be done, choosing acceptable formats such as foams and solutions over greasy ointments for daytime, moving messy treatments to weekends, and handing over ownership deliberately rather than by attrition. Two specifics worth raising: mental health, since depression and anxiety rates are elevated and this age group is particularly affected; and smoking, since starting now compounds a condition it will worsen for decades.

• Therapy guidePsoriasis therapy guide
• QuestionHow is psoriasis treated in children?
• QuestionIs it normal for psoriasis to affect my mood this much?

Practicalities dominate. Biologics require refrigeration, so a cool bag or medical travel case is needed, along with a letter from your clinician for airport security if you are carrying needles and a sharps container plan. Never put temperature-sensitive medication in hold luggage. Take enough for the trip plus a margin, since obtaining a specific biologic abroad ranges from difficult to impossible, and carry drugs in original labelled packaging with generic names written down, as brand names differ between countries. For methotrexate and other tablets, take the schedule into account across time zones. Beyond logistics: sunny climates often improve psoriasis substantially, though sunburn triggers new plaques so exposure should build gradually; swimming pools sting cracked plaques, and salt water suits many people better; and hotel toiletries are usually fragranced, so take your own. Two additions: declare psoriasis and its treatment on travel insurance, since undeclared conditions void cover, and check whether your destination requires any live vaccines, which are generally incompatible with biologics.

• Therapy guidePsoriasis therapy guide
• ToolShelf-Life Tracker
• QuestionWhat is injecting a biologic actually like?
• QuestionWhich vaccines can I have on psoriasis treatment?

Inheritance is a tendency rather than a transmission. Figures vary between studies, but the commonly cited pattern is around a one in six chance with one affected parent, rising substantially when both parents are affected, against a general population risk of a few percent. Most children of people with psoriasis never develop it. What is inherited is susceptibility across many genes, and whether it manifests depends on triggers — infection, injury, smoking, obesity, stress — several of which are modifiable. There is no genetic test worth doing, since the result would not change anything you do. What is useful: knowing the family history means a scaly patch in your child gets considered as psoriasis rather than treated as eczema for a year, and it means early attention if guttate spots appear after a sore throat. Two things worth saying to a worried parent: nothing you did caused it or transmitted it, and the treatment landscape now is unrecognisable from a generation ago, so the outlook for a child developing psoriasis today is considerably better than the one you may have experienced.

• Therapy guidePsoriasis therapy guide
• QuestionHow much of psoriasis is inherited?
• QuestionHow is psoriasis treated in children?

Systematic review of biologic response in skin-of-colour participants with psoriasis finds broadly comparable efficacy, which is reassuring, alongside a clear finding that these populations are markedly under-represented in the pivotal trials — meaning confidence rests on smaller numbers than for other groups. That under-representation is a legitimate thing to know rather than a reason for concern about a specific drug. What matters more in practice is access rather than pharmacology: documented disparities exist in referral rates, in receipt of specialist care, and in prescription of systemic and biologic treatment, and severity underestimation compounds them by keeping scores below funding thresholds. Two practical implications. If you are being managed with topicals for extensive or long-standing disease, ask explicitly about systemic options and what would qualify you. And if dyspigmentation is your main residual concern after plaques clear, say so, because that outcome is not captured by the scores used to judge whether treatment succeeded and is a documented reason people feel dismissed.

• Therapy guidePsoriasis therapy guide
• QuestionCould my psoriasis be graded as milder than it is?
• QuestionWhich biologic is the best one?

Post-inflammatory dyspigmentation after psoriasis is more visible and more persistent in richly pigmented skin, appearing as darker brown or notably paler patches where plaques have cleared, and taking three to twelve months to resolve depending on severity and site. Research on psoriasis in skin of colour makes the point explicitly: patients frequently regard the dyspigmentation as part of the disease and do not consider treatment successful until it has gone, which is a legitimate position and one that clinical severity scores do not capture at all. Two things follow. Say it at appointments — if your plaques have cleared and you are still distressed, that is worth naming rather than being told the psoriasis is controlled. And treat the modifiable parts: clearing plaques quickly limits how much pigment change accumulates, sun protection reduces contrast, and time does the rest. What does not help is continuing potent steroid on a flat mark, which adds risk without benefit. Skin-lightening products are generally unnecessary here and can cause their own problems.

• Therapy guidePsoriasis therapy guide
• ToolSunscreen Finder
• QuestionWhy are there marks where the plaques were?
• QuestionWhat does psoriasis look like on deeper skin?

This is measurable rather than anecdotal. Psoriasis is underdiagnosed in people with skin of colour, partly because clinicians vary in their ability to assess erythema across skin tones, and severity instruments built on lighter skin systematically underweight disease that is violaceous rather than red. Meanwhile reported body surface involvement is often greater in Black patients, so the disease being underestimated is frequently the more extensive disease. The consequence is delayed escalation and delayed access to systemic treatment, since funding criteria run on those same scores. What to do about it is concrete. Bring measures that do not depend on colour: how many areas are involved, how thick the plaques feel, itch scored out of ten, sleep lost, work affected, and the impact of dyspigmentation. Bring photographs from a bad period. Ask directly what threshold would justify escalation and whether you meet it. If a treatment plan has been unchanged for years while you remain affected, a second opinion is entirely reasonable.

• Therapy guidePsoriasis therapy guide
• ToolPASI Calculator
• ToolDerm Visit Prep
• QuestionWhat does psoriasis look like on deeper skin?
• QuestionWhat gets me access to a biologic?

Narrowband UVB is effective across skin tones, and the adjustment is one of dosing rather than suitability. Melanin absorbs ultraviolet light, so more energy is required to reach the same therapeutic effect in deeper skin, and phototherapy protocols set starting doses and escalation steps according to skin phototype for exactly this reason. That also means the burn threshold is higher, so the treatment tends to be well tolerated. Two considerations worth raising. Courses may need to run longer or to higher doses to achieve the same clearance, so a course that is not working by week four should prompt a dosing review rather than abandonment. And phototherapy can affect pigmentation — treated skin may darken overall, which some people welcome for evening out dyspigmentation and others do not, and it is worth discussing beforehand. Access is the bigger issue in practice: attendance two or three times weekly is the barrier for everyone, and home units are worth asking about. Sunbeds remain a poor substitute regardless of skin tone.

• Therapy guidePsoriasis therapy guide
• QuestionWhat is light treatment actually like?
• QuestionCan I have a light unit at home?

Plaque psoriasis on richly pigmented skin frequently appears violaceous, grey or dark brown instead of the salmon-pink shown in most textbooks, and the erythema that severity scores lean on is far harder to assess. Scale often appears thicker and more silvery against the darker background. Studies and expert surveys also report more extensive body surface involvement in Black patients than in white patients, alongside lower rates of diagnosis — a combination that points at recognition rather than biology. The practical consequences are two. Severity gets underestimated, both by clinicians using erythema-weighted scores and by patients comparing themselves to reference images that do not resemble their skin, which delays escalation. And the aftermath differs: plaques resolve leaving prominent hyper- or hypopigmented patches that take three to twelve months to fade, and many people do not consider treatment successful until those resolve. What helps: judge by thickness and area rather than colour, photograph in consistent light, and state impact in functional terms that survive translation across skin tones.

• Therapy guidePsoriasis therapy guide
• ToolPASI Calculator
• ToolProgress Photo Tracker
• QuestionWhy do the marks left behind bother me more than the plaques?
• QuestionCould my psoriasis be graded as milder than it is?

Standard scalp psoriasis advice assumes frequent shampooing, which conflicts with the care needs of textured, coiled or chemically treated hair, where washing every one to two weeks protects the hair. Forcing daily medicated shampoo damages hair and gets abandoned. Workable adaptations: use oil-based descaling preparations, including coconut-oil compound ointment, applied to the scalp and left on for hours or overnight before a wash day; apply steroid or vitamin D scalp solutions, oils or foams directly to the scalp between washes, parting section by section, since these do not require rinsing; and reserve the tar or medicated shampoo for wash day, left in contact for several minutes. Avoid heavy petrolatum-based products if they interfere with your styling, and be cautious with relaxers and heat during flares, since chemical processing on inflamed scalp skin stings and can Koebnerise. Two extras: braiding and tight styles pull on inflamed scalp and are worth loosening during a flare, and hair loss during a bad phase is usually temporary and recovers as the scalp settles.

• Therapy guidePsoriasis therapy guide
• ReadThe Deadliest Place to Get Melanoma Is the One Spot You Never Sunscreen
• QuestionWhat is the right way to treat scalp psoriasis?
• QuestionCan I dye my hair or have salon treatments with scalp psoriasis?

Two mechanisms make clothing relevant. Friction and pressure can trigger the Koebner phenomenon, so tight waistbands, bra straps, belts and repeated rubbing at collars are worth loosening, particularly over sites that already flare. And rough fabrics, especially wool against plaques, irritate mechanically. Cotton and other smooth breathable fabrics are the usual recommendation; seams, labels and elastic edges cause localised patches. Beyond the physical, there is the practical business of living with shedding scale: darker clothing hides it, patterned fabrics disguise it, and keeping a lint roller to hand is a small thing that reduces daily self-consciousness considerably. Layers help with the temperature swings that provoke itch. Two more notes. Emollients and coal tar preparations stain and degrade fabric, so old clothing and bedding for treatment nights saves ruining good clothes — and paraffin-based emollients on fabric are flammable, which matters near naked flames. And feeling obliged to cover up in hot weather is a real cost worth mentioning at appointments as part of impact.

• Therapy guidePsoriasis therapy guide
• QuestionWhat sets off a psoriasis flare?
• QuestionWhat helps with the constant flaking?

Exercise earns a place here beyond general health advice. Higher physical activity is associated with lower incidence and severity of psoriasis in cohort studies, plausibly through effects on weight and systemic inflammation, and it directly targets the cardiovascular and metabolic risk psoriasis raises. For people with psoriatic arthritis, appropriate exercise maintains joint function rather than damaging it, though the type matters and physiotherapy input is worth having. The obstacles are practical rather than medical. Sweat stings fissured plaques, friction from equipment and clothing can provoke Koebner reactions, changing rooms and shared showers feel exposing, and joint pain makes some activities difficult. Workable adaptations: smooth breathable kit, emollient before and after, prompt showering and moisturising, swimming or cycling if impact hurts, and choosing settings where you feel comfortable. Two things worth saying: reluctance to be seen in gym clothing is a legitimate and common barrier that deserves acknowledging rather than pushing through, and if joint pain is limiting you, that needs assessing rather than working around.

• Therapy guidePsoriasis therapy guide
• ReadThe Workout That's Good for Your Skin Is Also Breaking It Out
• QuestionWhy am I being told to check my blood pressure and cholesterol?
• QuestionShould I be screened for psoriatic arthritis?

Shedding is one of the least discussed and most wearing aspects of psoriasis: scale on desks, in beds, on dark clothing, and the constant management of where you sit and what you wear. Practical measures genuinely help. Emollients applied generously reduce scale substantially. Descaling preparations with salicylic acid or urea lift what is already there. A lint roller, a small brush, and keeping a spare top at work sound trivial and reduce daily anxiety. Vacuum and change bedding more often, and use darker or patterned fabrics. Scalp involvement produces the most visible shedding and responds well to a proper descaling and treatment routine. What matters more than any of that: heavy scaling is a marker of inadequately controlled disease. If your day is organised around managing flakes, that is not a housekeeping problem, it is a treatment problem, and it is worth stating in exactly those terms at an appointment — impact on daily life is an explicit criterion for escalating treatment, and this is precisely the kind of impact that goes unmentioned.

• Therapy guidePsoriasis therapy guide
• QuestionWhich moisturiser should I use on plaques?
• QuestionWhen should treatment be stepped up?

The practical frictions are real: visible plaques, shedding on shared bedding, greasy emollients at night, and the exhaustion of concealment. Concealment is usually the costliest part, because it means treating worse — skipping the night-time ointment, staying dressed, avoiding closeness. A short factual explanation to a partner tends to land better than unexplained avoidance: what it is, that it is not contagious, that it fluctuates, and what actually helps. Practical negotiations worth having: old sheets or towels on treatment nights, a cooler room, and separate covers if heat provokes itch. On intimacy specifically, genital psoriasis affects a large proportion of people, causes discomfort and pain during sex, is frequently mistaken for thrush or an infection, and is highly treatable with the right topical — but it goes unmentioned in consultations more than almost anything else. Raising it is worth the awkwardness. Two additions: lubricants and condoms are worth choosing fragrance-free, and psoriasis is not sexually transmitted in any sense, which occasionally needs saying explicitly.

• Therapy guidePsoriasis therapy guide
• QuestionCan psoriasis affect the genitals?
• QuestionCan psoriasis spread to other people?

Plaques sit over dilated capillaries close to the surface, so shaving across one bleeds readily, and any skin injury can trigger fresh psoriasis through the Koebner phenomenon. Practical approach: soften the area first with a warm shower and emollient; use a sharp single or double blade rather than a multi-blade cartridge that cuts below the surface; go with the grain, without stretching the skin; and work around raised plaques rather than over them where possible. An electric trimmer leaving slight stubble avoids skin contact almost entirely and is the safer option during a flare. Avoid alcohol-based aftershaves, which sting broken skin, in favour of a bland emollient. Depilatory creams are strongly alkaline and best avoided on plaques; waxing is worse, since it strips skin along with hair. Two additions: laser hair removal is possible on clear skin and should be discussed with someone who knows about psoriasis, with a test patch; and scalp and beard-area psoriasis complicates shaving further and is worth treating properly rather than working around indefinitely.

• Therapy guidePsoriasis therapy guide
• ReadMen's Skincare, Debugged: You Need Three Products, Not Twelve
• QuestionWhat sets off a psoriasis flare?
• QuestionCan I get a tattoo or piercing with psoriasis?

You are generally under no obligation to disclose a diagnosis to colleagues, though telling a manager can unlock practical support. What is worth raising: time for treatment appointments, particularly phototherapy two or three times weekly for months; uniform or PPE that irritates or presses on plaques; hand involvement in wet or manual work, which is both painful and a potential occupational matter; and the fatigue that accompanies inflammatory disease and psoriatic arthritis. In many jurisdictions a long-term condition with substantial impact may attract legal protection and a duty to consider reasonable adjustments, and occupational health referral is the usual route. On visible plaques and shedding: darker clothing, a lint roller in a drawer, and emollient kept at your desk are small practical fixes. Questions from colleagues are best handled with one prepared factual sentence — a long-term skin condition, not contagious — repeated without elaboration. Two additions: comment about your skin crossing into hostility is a workplace issue rather than something to absorb, and needing to hide your hands is a legitimate impact to report medically.

• Therapy guidePsoriasis therapy guide
• QuestionCan I get time off or adjustments at work?
• QuestionWhat do I do if I'm refused service because of my skin?

Bathing helps psoriasis when it is used to soften and lift scale and hurts when it dries the skin further. Lukewarm water rather than hot, ten to fifteen minutes for a soak, using a soap substitute or an emollient wash rather than soap, which raises skin pH and strips lipids. Oatmeal, Epsom or Dead Sea salt additives are traditional and pleasant, with limited but not absent evidence, and coal tar bath preparations are still prescribed. Pat dry rather than rubbing, then apply emollient within a few minutes while skin still holds water — this step does most of the work and is the one most often skipped. During a soak, thick scale can be gently loosened with a soft cloth, but never scraped or scrubbed, since injury provokes new plaques. Two practical extras: a bath is a good opportunity to apply descaling preparations beforehand and remove them afterwards, and if hot showers are your main comfort, a cooler final minute and immediate emollient recovers most of the ground lost.

• Therapy guidePsoriasis therapy guide
• QuestionWhich moisturiser should I use on plaques?
• QuestionShould I pick or scrub the scale off?

Itch in psoriasis is underestimated — a majority of people experience it, and it worsens at night as skin temperature rises and distraction falls. Measures that help: a cooler bedroom and lighter bedding, since heat drives itch; a generous layer of emollient or ointment shortly before bed, which reduces the dryness component; covering the worst areas with cotton clothing to blunt unconscious scratching, which matters because scratching provokes new plaques; short nails; and a cool damp cloth held against a burning area long enough to break the loop. Sedating antihistamines can help occasionally for sleep rather than for itch itself. Scale softening and removal before bed reduces the tight, itchy feeling. What matters most: persistent itch and disturbed sleep are markers of inadequately controlled disease and are explicit factors in escalation decisions, so report them as a number of disturbed nights per week rather than as being tired. Two additions: psoriasis is associated with sleep disturbance independently of itch, and joint pain waking you is a separate signal worth mentioning.

• Therapy guidePsoriasis therapy guide
• ToolItch Scale (0–10)
• QuestionWhen should treatment be stepped up?
• QuestionShould I pick or scrub the scale off?

Swimming is worth protecting for exercise, joint-friendly movement if you have psoriatic arthritis, and simple enjoyment, and the obstacles are manageable. Chlorinated water dries the skin and stings fissured plaques, so apply a thick emollient or ointment before swimming as a partial barrier, rinse thoroughly in fresh water immediately afterwards rather than letting pool water dry on you, and moisturise again while damp. Salt water suits many people better, and sea swimming combined with sunlight is a classic combination that genuinely helps. The larger obstacle is often social: people with visible plaques are still asked to leave pools by staff or stared at by others, which has no medical basis, since psoriasis is not contagious, and in many jurisdictions exclusion on that basis may be unlawful. Carrying a brief note from a clinician resolves it if you want the option. Two additions: changing-room showers are usually hot and the provided products fragranced, so take your own; and swimwear that covers plaques is a personal choice, not a requirement.

• Therapy guidePsoriasis therapy guide
• QuestionWhat do I do if I'm refused service because of my skin?
• QuestionCan psoriasis spread to other people?

Psoriasis is controlled rather than cured, and stopping treatment when clear is the single commonest route back to where you started. With topicals, the usual approach is stepping down rather than stopping — reducing potent steroid to intermittent use while continuing a vitamin D analogue, with emollients throughout. With systemic treatment the evidence is clearer: most people relapse within months of discontinuation, though a minority stay clear far longer, and the withdrawal of some drugs carries specific risks, notably oral steroids and, less predictably, abrupt cessation after long potent topical use. There are legitimate reasons to stop or pause — pregnancy planning, surgery, infection, side effects, or a considered trial off treatment after prolonged remission — and those are conversations rather than unilateral decisions, because how you stop matters. Two practical points: if you have stopped and relapsed, restarting the same treatment usually works again; and if you are stopping because the regimen is unmanageable, saying so opens the door to a simpler one rather than to none at all.

• Therapy guidePsoriasis therapy guide
• QuestionWhat does long-term maintenance involve?
• QuestionHow long does a clear period usually last?

The honest answer is variable and largely unpredictable. Guttate psoriasis frequently resolves and may never recur, particularly in children and young adults, though a proportion progress to chronic plaque disease. Chronic plaque psoriasis usually persists lifelong, with severity fluctuating over years and long remissions occurring in some people spontaneously. Nothing reliably predicts who will have a mild course and who will not, though earlier onset, extensive disease, nail involvement and a strong family history are associated with more persistent disease. What has changed the outlook is treatment rather than natural history: sustained near-complete clearance is achievable for a large proportion of people on current systemic treatments, which makes the question of whether it burns out less pressing than it was a generation ago. Two things worth holding onto. Long quiet periods are common and worth enjoying without dismantling the maintenance that produced them. And returning after years is not a failure or a sign of deterioration; it is what a relapsing condition does.

• Therapy guidePsoriasis therapy guide
• QuestionHow long does a clear period usually last?
• QuestionCan I stop treatment once I'm clear?

A flare after prolonged stability usually has an identifiable antecedent, and working through the list is more productive than assuming the disease has changed character. Infection, streptococcal throat infection above all. A new medication — beta-blockers, lithium, antimalarials — or a course of oral steroids that has ended. Treatment drift, where maintenance quietly stopped once the skin looked fine. Weight change, which affects both severity and weight-based drug dosing. A stressful period or significant sleep disruption. Smoking resumed. Loss of response to a biologic through antibody formation, if you are on one. Occasionally a flare after stability is not psoriasis at all — a drug eruption, tinea, or another condition superimposed — which is worth considering if it looks or behaves differently. What to do: report it rather than waiting for a scheduled review, mention anything new in the preceding two months including over-the-counter drugs and supplements, and step maintenance treatment back up promptly, since a flare caught early settles far faster than one left to establish.

• Therapy guidePsoriasis therapy guide
• ToolSkin Flare Diary
• QuestionCan my other medications be making it worse?
• QuestionWhy did I flare while on treatment?

Prevention in psoriasis is genuinely possible even though the disease cannot be cured. The highest-yield measure is maintenance treatment applied to historically affected sites rather than stopping when clear. Beyond that, several triggers are actionable: get streptococcal throat infections assessed and treated rather than ignored; protect skin from injury, since cuts, scratches, sunburn, tattoos and even tight clothing can seed new plaques; stop smoking, which improves both severity and treatment response; manage weight, since reduction improves psoriasis independently; moderate alcohol; and check with a prescriber before starting medications known to provoke it. Emollients used consistently reduce cracking and itch and make flares less likely to escalate. What is less within your control: seasonal change, stress, and the disease's own rhythm. Two practical additions: have your treatment in the house before you need it rather than requiring a prescription mid-flare, and act on the first signs — thickening, itch returning at a known site — rather than waiting for a plaque to establish.

• Therapy guidePsoriasis therapy guide
• ToolSkin Flare Diary
• QuestionWhat sets off a psoriasis flare?
• QuestionWhat does long-term maintenance involve?

Maintenance is designed to be sustainable across years, so it is deliberately smaller than the regimen that cleared you. For topical-managed psoriasis: emollients continued daily and generously; a vitamin D analogue or a steroid combination reduced to intermittent application, often twice weekly, on the sites that historically relapse; and descaling preparations kept for when scale builds. For systemic-managed psoriasis: continuing the drug at its maintenance dose and interval, with monitoring, plus topicals for any residual stubborn plaques. Alongside either, the general health parts of maintenance matter and get neglected — blood pressure, lipids, glucose and weight, given the cardiometabolic risk, and an annual check on joint symptoms. Two practical points. Step down gradually and watch, rather than stopping and rediscovering the answer; and treat a breakthrough flare by stepping back up promptly rather than waiting, since early intervention settles it far faster. Review annually even when stable, since treatment options have expanded considerably and what was appropriate five years ago may not be the best available now.

• Therapy guidePsoriasis therapy guide
• ToolPsoriatic Arthritis Screen
• QuestionCan I stop treatment once I'm clear?
• QuestionWhy am I being told to check my blood pressure and cholesterol?

Relapse mapping precisely onto old sites is characteristic and has a well-described explanation. Tissue-resident memory T cells persist in skin that has previously been psoriatic, remaining after the visible plaque resolves and after inflammation subsides, and they can reactivate locally to reproduce disease in exactly the same place. That is why elbows, knees, scalp and the lower back recur so faithfully, and it is part of why psoriasis is considered a disease of the whole skin rather than of the visible patches. Mechanical factors reinforce it — elbows and knees are subject to constant pressure and friction, which contributes through the Koebner phenomenon. Two practical consequences. Maintenance treatment applied to known sites when they look clear is more effective than waiting for return, which is the same logic that underpins proactive treatment in eczema. And if a single site recurs while everything else stays controlled, it is worth a look for a local factor — pressure, friction, an unrecognised infection, or a different diagnosis at that site — rather than escalating whole-body treatment for one patch.

• Therapy guidePsoriasis therapy guide
• QuestionWhat does long-term maintenance involve?
• QuestionWhat sets off a psoriasis flare?

Being turned away from a pool, a salon, a gym or a beauty treatment because of visible plaques is a documented and recurring experience, and it has no medical basis — psoriasis cannot be transmitted by any route. In the moment, a short factual statement often resolves it: it is a long-term immune condition, it is not contagious, and a clinician's note can confirm that. Carrying such a note is worth doing if these situations recur. Where it does not resolve, asking for the refusal and the reason in writing changes the tone considerably, because in many jurisdictions a long-term health condition with substantial impact is protected and refusing goods or services on that basis may be unlawful discrimination. National psoriasis charities have template letters and advice lines for exactly this. Two things worth saying. The impulse to simply leave rather than argue is entirely understandable and not a failure. And these experiences count as impact — reporting them at appointments is legitimate and contributes to the case for more effective treatment.

• Therapy guidePsoriasis therapy guide
• QuestionCan psoriasis spread to other people?
• QuestionCan I swim with psoriasis?

Having a prepared line handles most encounters better than an explanation, because explaining invites suggestions about diet, stress, creams and cures that a well-meaning person read somewhere, and you are then managing their enthusiasm as well as your skin. Name it, note it is not catching, say it is managed, change the subject. For people closer to you — a partner, family, close colleagues — more detail genuinely helps, particularly the parts that affect them: that it fluctuates without meaning anything, that shedding is not a hygiene matter, that treatment appointments are frequent, and that joint pain may be part of it. For children with psoriasis, giving them their own sentence is protective, since being asked repeatedly without an answer ready is where self-consciousness sets in. Two additions. If someone offers a cure they have read about, you are not obliged to engage — most people are being kind rather than judgmental, and a brief thank-you closes it. And if comment crosses into hostility at work or school, that is a formal matter rather than something to absorb.

• Therapy guidePsoriasis therapy guide
• QuestionWhat do I do if I'm refused service because of my skin?
• QuestionWhat helps with visible psoriasis at work?

The psychological burden of psoriasis is well documented and consistently underestimated. Rates of depression and anxiety are markedly higher than in the general population, and studies find the association driven by itch, sleep disruption, visibility and social consequences rather than by body surface area — which is why someone with limited but visible disease can be more affected than someone with widespread plaques under clothing. Add the specific indignities: being stared at, asked to leave pools, refused salon services, and assumed to be contagious. There is also a plausible biological contribution, since the inflammatory cytokines involved in psoriasis are implicated in depression, and some people report mood improving on systemic treatment beyond what clear skin alone would explain. Two things follow. Psychological impact is an explicit criterion in escalation decisions, so saying it plainly at appointments changes the plan rather than sounding self-indulgent. And if low mood has persisted independently of your skin, it deserves its own treatment alongside rather than waiting for clearance.

• Therapy guidePsoriasis therapy guide
• ToolItch Scale (0–10)
• QuestionWhen should I get mental health support?
• QuestionWhat do I do if I'm refused service because of my skin?

Chronic conditions ask for a kind of acceptance that is different from resignation, and the timing matters: coming to terms with psoriasis is far harder while it is uncontrolled, which is why effective treatment is part of the psychological work rather than separate from it. What people describe as helping. Understanding the condition properly, because uncertainty is corrosive and psoriasis is well understood. Reframing the goal from cure to control, which is achievable and increasingly means near-clear skin. Contact with others who have it, through patient organisations and support groups, which reduces the isolation that visible chronic conditions produce more than almost any intervention. Structured psychological support, which has evidence for improving both mood and skin outcomes in inflammatory skin disease. And treating flares as episodes rather than as verdicts. Two honest points: grief about a body that has changed is legitimate and common, and it is not vanity; and the treatment landscape has transformed within a decade, so an outlook formed years ago may simply be out of date.

• Therapy guidePsoriasis therapy guide
• QuestionIs it normal for psoriasis to affect my mood this much?
• QuestionWhen should I get mental health support?

Balneotherapy and climatotherapy have a longer research history than most complementary approaches, with Dead Sea treatment in particular showing substantial clearance rates in studies — the combination of a unique ultraviolet spectrum at low altitude, mineral-rich water, and several weeks of rest away from ordinary stressors. Some health systems have historically funded it. What is harder to establish is which component does the work, and whether a spa weekend elsewhere delivers anything comparable, which is doubtful. Other balneotherapy approaches, including sulphur and salt baths, appear in guideline reviews of alternative modalities with limited evidence. Practical realities: cost, time away, and the fact that improvement fades over months after returning, so it is a treatment episode rather than a cure. Two things worth knowing. Sun exposure needs to be graduated, since sunburn triggers new plaques and would undo the benefit. And if a trip like this appeals, it is worth asking whether your health system funds any form of climatotherapy, since some do for severe disease and it is rarely offered unprompted.

• Therapy guidePsoriasis therapy guide
• QuestionDoes sunlight genuinely help psoriasis?
• QuestionDo natural treatments work for psoriasis?

The governing consideration is skin injury. Microneedling, laser resurfacing, chemical peels, dermabrasion and even aggressive extractions all create controlled damage, and controlled damage is exactly what provokes psoriasis at the treated site. That does not make them impossible, but it changes the calculation: they should be done on clear, well-controlled skin, away from sites where your psoriasis habitually appears, ideally with a test area, and by someone told about the condition. Injectable treatments are lower risk, since they do not injure the surface meaningfully, though injecting through an active plaque is avoided. If you are on immunosuppressive treatment, infection risk after any procedure is higher and timing should be discussed with your dermatology team. Two practical points: ask what the aftercare involves, since heat, friction and occlusion feature in many protocols and none of them helps psoriasis; and if the reason for wanting a procedure is the dyspigmentation left behind by cleared plaques, time and sun protection usually resolve that without intervention.

• Therapy guidePsoriasis therapy guide
• QuestionCan I get a tattoo or piercing with psoriasis?
• QuestionWhy do the marks left behind bother me more than the plaques?

Before systemic treatments transformed psoriasis care, intensive inpatient and day-treatment regimens were the mainstay, and they still exist in some centres and remain genuinely effective. The model combines thorough descaling, application of tar or dithranol by trained staff, phototherapy, and emollient, delivered daily under supervision for a period of days or weeks. Remissions achieved this way can be long. What it offers that outpatient care cannot: correct application, which is the commonest failure of topical treatment; time and teaching; and a break from managing a difficult regimen alone. Where it survives it is typically used for severe unstable disease, for people who cannot take systemic treatment, and occasionally for those who want an alternative to drugs. Availability has shrunk considerably as biologics have expanded, and access varies widely by region. It is worth asking about if you have failed topical treatment at home but are reluctant to start systemic therapy, or if you suspect application technique is the real problem — a nurse-led education session alone changes outcomes for many people.

• Therapy guidePsoriasis therapy guide
• QuestionIn what order do I apply everything?
• QuestionWhat if nothing has worked?

The excimer laser or lamp emits light at 308 nm, close to the wavelength of narrowband UVB, and applies it only to the plaque rather than to the whole body. That allows much higher doses per session than a whole-body cabinet would tolerate, which means fewer sessions and faster clearance for a limited number of plaques, while unaffected skin receives no exposure at all. It suits stubborn localised disease — a persistent elbow or knee, scalp patches, and palmoplantar involvement — and is used in some centres for genital and other awkward sites. Typical courses run to ten or more sessions, usually twice weekly. Side effects are those of concentrated UVB: redness, occasional blistering if dosed aggressively, and pigmentation of the treated area. Its limitations are practical: it is impractical for widespread disease, it requires a centre with the equipment, and it is not universally funded. Ask about it specifically if you have a small number of resistant plaques and are otherwise well controlled, since it may avoid escalating systemic treatment for a localised problem.

• Therapy guidePsoriasis therapy guide
• QuestionWhat is light treatment actually like?
• QuestionCan I have a light unit at home?

Nail psoriasis is hard to treat because the target sits under a plate that blocks almost everything applied to it, and because nails grow slowly, so any improvement takes six to twelve months to become visible. Options in order of intensity. Topical treatments — potent steroids, vitamin D analogues, tazarotene — applied to the nail folds and under the free edge, with modest results. Intralesional corticosteroid injection into the nail fold, which is effective, particularly for pitting and thickening, and is more uncomfortable than most procedures on this page: it is usually done with local anaesthetic and repeated every few weeks initially. Systemic treatment, which is where the substantial responses occur — several biologics have specific evidence for nail improvement, and nail disease is itself an argument for escalating. Practical care matters too: keep nails short, avoid manicures that push back cuticles, wear gloves for wet work. Two additions: fungal infection commonly coexists and is worth excluding, and nail involvement raises the odds of psoriatic arthritis.

• Therapy guidePsoriasis therapy guide
• QuestionWhat do the changes in my nails mean?
• QuestionShould I be screened for psoriatic arthritis?

Psoriasis and inflammatory bowel disease share immune pathways and genetic associations, and Crohn's disease in particular is more common in people with psoriasis than in the general population. Symptoms worth reporting rather than attributing to diet or stress: persistent diarrhoea, blood or mucus in the stool, abdominal pain, unexplained weight loss, mouth ulcers and fatigue. The reason to raise it with your dermatologist rather than only with a gastroenterologist is specific and important: IL-17 inhibitors, a major class of psoriasis biologics, can precipitate or worsen inflammatory bowel disease, so a history of bowel symptoms changes which drug should be chosen, and several other agents treat both conditions. Coeliac disease is also more common in psoriasis, which is a separate consideration and one of the few situations where gluten avoidance is genuinely indicated. What to do: mention bowel symptoms before a biologic is selected rather than after, and if symptoms begin while on an IL-17 agent, report them promptly rather than waiting for a scheduled review.

• Therapy guidePsoriasis therapy guide
• QuestionWhich biologic is the best one?
• QuestionWhat else is psoriasis associated with?

Two separate concerns converge. Non-alcoholic fatty liver disease occurs at raised rates in psoriasis, linked to the shared metabolic syndrome association, and it can progress silently to fibrosis. Separately, methotrexate and acitretin are both hepatotoxic in a dose-related way, and alcohol adds to the load. That combination is why liver monitoring features so prominently in psoriasis care, and why a fibrosis marker or elastography scan is used in some systems before and during long-term methotrexate rather than relying on enzyme levels alone, which can be normal despite significant fibrosis. What follows practically. Be accurate about alcohol intake rather than diplomatic, since the monitoring plan depends on it. Take weight, diabetes risk and lipids seriously, since fatty liver is driven by the same factors. Do not skip monitoring because you feel well — liver injury is silent until it is not. And if abnormal results appear, the usual response is dose adjustment or a switch rather than abandoning treatment altogether, so it is worth raising rather than avoiding the test.

• Therapy guidePsoriasis therapy guide
• QuestionWhat is methotrexate like to take?
• QuestionWhy am I being told to check my blood pressure and cholesterol?

Psoriasis is a systemic inflammatory disease, and the same inflammation implicated in the skin is associated with atherosclerosis and metabolic dysfunction. Studies consistently find approximately twice the risk of cardiovascular disease and metabolic syndrome compared with the general population, with the association strongest in more severe disease, and comorbidities including hypertension, dyslipidaemia, diabetes, obesity and fatty liver disease occurring at raised rates. Guidance therefore recommends active screening: blood pressure, fasting glucose or HbA1c, lipids, weight and waist circumference measured regularly, usually annually for moderate-to-severe disease, by a dermatologist or primary care clinician. This is not incidental to psoriasis care; for many people it is the part with the greatest effect on how long they live. What follows practically: ask who is doing these checks, since they fall between specialties and get missed; treat smoking cessation, activity and weight as part of psoriasis management rather than as unrelated lifestyle advice; and note that psoriasis is not included in most standard cardiovascular risk calculators, which may therefore underestimate your risk.

• Therapy guidePsoriasis therapy guide
• QuestionIs psoriasis only a cosmetic problem?
• QuestionDoes my weight affect psoriasis?

There are two mechanisms and they are not mutually exclusive. The obvious one is psychosocial: visible disease, itch, sleep disruption, stigma and exclusion produce measurable psychological harm, and studies find impact rather than surface area predicts distress. The less obvious one is biological. The cytokines central to psoriasis, particularly tumour necrosis factor and interleukin-17, are implicated in depression through effects on neurotransmitter metabolism and neuroinflammation, and some studies of psoriasis biologics have found improvements in depressive symptoms that appear to exceed what skin clearance alone would explain. That does not mean a biologic treats depression, and it should not displace psychological treatment where that is needed. What it does mean is that dismissing the mood component as merely a reaction to appearance is too simple, and that treating the inflammation properly is part of addressing it. Two practical points: report mood symptoms to whoever manages your psoriasis, and treat depression on its own terms alongside rather than waiting for clear skin.

• Therapy guidePsoriasis therapy guide
• QuestionIs it normal for psoriasis to affect my mood this much?
• QuestionWhen should I get mental health support?

Psoriasis travels with a recognisable set of conditions, and knowing the list helps you connect symptoms that might otherwise be reported separately or not at all. Psoriatic arthritis is the most important and the most actionable. Inflammatory bowel disease, particularly Crohn's disease, occurs at raised rates and matters practically because IL-17 inhibitors can worsen it, so bowel symptoms should be mentioned before a biologic is chosen. Uveitis — eye pain, redness and light sensitivity — is part of the same immune cluster and needs prompt ophthalmology assessment. Non-alcoholic fatty liver disease is common and relevant to methotrexate decisions. Chronic kidney disease appears in some studies. Depression and anxiety are substantially raised. Coeliac disease is more frequent than in the general population. What to do with this: report symptoms in these systems to whoever manages your psoriasis rather than assuming they are unrelated, since the connection frequently changes the treatment choice, and ensure someone is coordinating the general health screening that the association warrants.

• Therapy guidePsoriasis therapy guide
• ToolPsoriatic Arthritis Screen
• QuestionWhy am I being told to check my blood pressure and cholesterol?
• QuestionShould I be screened for psoriatic arthritis?

The two were long thought to be nearly mutually exclusive because they involve different immune pathways, but coexistence is documented and increasingly recognised, and some people have overlapping features that resist neat classification. Where both are present, treatment is regional rather than uniform: eczematous areas need emollient volume and anti-inflammatory treatment, while psoriatic plaques respond to vitamin D analogues and coal tar preparations that would be irritating and unhelpful on eczema. Two practical complications are worth knowing. Systemic treatment choices differ, since drugs targeting one pathway can occasionally unmask or worsen the other — paradoxical eczema on some psoriasis biologics is a recognised phenomenon. And distinguishing which patch is which is genuinely difficult in a mixed picture, so biopsy is used more often here than in either condition alone. If you have been treated for one for years without adequate control, and some areas behave differently from others, that observation is worth raising specifically rather than assuming a single diagnosis explains everything.

Shared with Eczema, where this answer lives.

• Therapy guidePsoriasis therapy guide
• ToolPASI Calculator
• ToolPsoriatic Arthritis Screen
• QuestionWhat tells eczema and psoriasis apart?
• QuestionWhat if adult eczema won't respond to anything?

Price and efficacy diverge sharply in this category. The topicals that genuinely clear plaques — vitamin D analogues, potent steroids and their combinations — are prescription-only, so no amount of retail spending buys equivalent efficacy. Over the counter, the useful products are emollients, salicylic acid or urea preparations, and coal tar, and none of those needs to be expensive; plain paraffin ointment is among the most effective occlusives available and costs very little. Where premium products can earn their place: a texture pleasant enough that you apply it four times a day rather than once, and pump packaging that stays hygienic. What is not worth the money: psoriasis-branded ranges at several times the price of identical basics, creams promising to reduce plaques without a named active, supplement protocols, and the accumulated cost of trying something new every few weeks. Two suggestions: ask whether emollients and descaling preparations can be prescribed by quantity where you live, and spend on volume rather than sophistication, since quantity is what actually changes the scale.

• Therapy guidePsoriasis therapy guide
• ToolDupe Finder
• QuestionWhat does psoriasis actually cost to treat?
• QuestionWhich moisturiser should I use on plaques?

Quantity is the quiet determinant of whether topical treatment works, and prescriptions are frequently written for a fraction of what is needed. For widespread psoriasis, emollient use runs to hundreds of grams a week, and if a 500 gram tub is lasting you a month, you are applying far less than intended. Medicated topicals are different — they go on plaques only and have weekly maximums, particularly vitamin D analogues where calcium absorption sets a ceiling, so more is not better there. The fingertip unit gives a workable measure: a line of cream from fingertip to first crease covers about two adult hand areas. What to do with this. Ask for emollients by quantity and in large pump dispensers rather than accepting whatever appears, and say how much you are getting through so the prescription matches reality. Running out is a treatment failure, not an inconvenience. Two additions: keep tubs in more than one room so applications actually happen, and if a regimen is too burdensome to complete, say so and get it simplified rather than silently doing half of it.

• Therapy guidePsoriasis therapy guide
• ToolFTU Calculator
• QuestionWhich moisturiser should I use on plaques?
• QuestionWhat does psoriasis actually cost to treat?

Two checks settle most purchases. First, is there an active doing something specific: salicylic acid or urea for descaling, coal tar for its own anti-psoriatic effect, or a straightforward emollient base built on petrolatum, paraffin, glycerin or ceramides. Second, is the ingredient list short and free of fragrance, since plaques are broken skin and fragrance is a common sensitiser. What carries no information: dermatologist-tested, clinically proven, natural, and psoriasis-branded packaging, none of which is regulated or meaningful. Two specific cautions for this condition. Products sold as herbal or natural psoriasis creams have repeatedly been found to contain undeclared potent corticosteroids, which means people use a strong steroid unknowingly and without supervision — a genuine risk rather than a theoretical one, particularly with products bought online from unregulated sources. And anything promising to cure psoriasis is misrepresenting a chronic immune condition. Buy simple, buy large, and put the money into quantity rather than novelty, since the volume of emollient used matters far more than which one.

• Therapy guidePsoriasis therapy guide
• ToolIngredient Decoder
• QuestionDo natural treatments work for psoriasis?
• QuestionWhich moisturiser should I use on plaques?

Psoriasis attracts constant product experimentation, partly because the condition is visible and frustrating and partly because the market is full of things promising more than they deliver. The cost is real: money, and the inability to attribute any change to anything. A better rhythm. Establish the base — emollient, descaling preparation, prescribed active — and hold it unchanged for at least eight weeks. Change one thing at a time thereafter, with a few weeks between changes. Test a genuinely new product on a small area for five to seven days before applying it widely, since plaques are broken skin and irritant reactions are common. Judge irritation at one week and efficacy at eight, since those questions run on different clocks. Legitimate reasons to change: a product that consistently stings, a reformulation, a seasonal need for something richer, or eight weeks of correct use without benefit. Not legitimate: a bad week, a recommendation, or a new launch. Flares happen on good regimens, and swapping in response teaches you nothing.

• Therapy guidePsoriasis therapy guide
• ToolPatch Test Log
• QuestionAm I actually improving?
• QuestionAre expensive psoriasis creams worth the money?